Author: "Park CW" - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Park CW"' showing total 1,654 results

Start Over Author "Park CW"

1,654 results on '"Park CW"'

1. Mucosal Penetrative Polymeric Micelle Formulations for Insulin Delivery to the Respiratory Tract

Author: Kang JH, Jeong JH, Kwon YB, Kim YJ, Shin DH, Park YS, Hyun S, Kim DW, and Park CW
Subjects: insulin, polyethylene glycol, cell-penetrating peptide, aerodynamic properties, mucus penetration, Medicine (General), R5-920
Abstract: Ji-Hyun Kang,1,2,&ast; Jin-Hyuk Jeong,1,&ast; Yong-Bin Kwon,1 Young-Jin Kim,1 Dae Hwan Shin,1 Yun-Sang Park,3 Soonsil Hyun,1 Dong-Wook Kim,4 Chun-Woong Park1 1College of Pharmacy, Chungbuk National University, Cheongju, 28160, Republic of Korea; 2School of Pharmacy, Institute of New Drug Development, and Respiratory Drug Development Research Institute, Jeonbuk National University, Jeonju, Republic of Korea; 3Research & Development Center, P2K Bio, Cheongju, Republic of Korea; 4College of Pharmacy, Wonkwang University, Iksan, 54538, Republic of Korea&ast;These authors contributed equally to this workCorrespondence: Chun-Woong Park, College of Pharmacy, Chungbuk National University, Cheongju, 28160, Republic of Korea, Tel +82-43-261-3330, Fax +82-43-268-2732, Email cwpark@cbnu.ac.kr Dong-Wook Kim, College of Pharmacy, Wonkwang University, Iksan, 54538, Republic of Korea, Tel +82-63-229-7130, Fax +82-63-850-7309, Email pharmengin@gmail.comPurpose: Effective mucosal delivery of drugs continues to pose a significant challenge owing to the formidable barrier presented by the respiratory tract mucus, which efficiently traps and clears foreign particulates. The surface characteristics of micelles dictate their ability to penetrate the respiratory tract mucus. In this study, polymeric micelles loaded with insulin (INS) were modified using mucus-penetrative polymers.Methods: We prepared and compared polyethylene glycol (PEG)-coated micelles with micelles where cell-penetrating peptide (CPP) is conjugated to PEG. Systematic investigations of the physicochemical and aerosolization properties, performance, in vitro release, mucus and cell penetration, lung function, and pharmacokinetics/pharmacodynamics (PK/PD) of polymeric micelles were performed to evaluate their interaction with the respiratory tract.Results: The nano-micelles, with a particle size of < 100 nm, exhibited a sustained-release profile. Interestingly, PEG-coated micelles exhibited higher diffusion and deeper penetration across the mucus layer. In addition, CPP-modified micelles showed enhanced in vitro cell penetration. Finally, in the PK/PD studies, the micellar solution demonstrated higher maximum concentration (Cmax) and AUC0-8h values than subcutaneously administered INS solution, along with a sustained blood glucose-lowering effect that lasted for more than 8 h.Conclusion: This study proposes the use of mucus-penetrating micelle formulations as prospective inhalation nano-carriers capable of efficiently transporting peptides to the respiratory tract.Keywords: insulin, polyethylene glycol, cell-penetrating peptide, aerodynamic properties, mucus penetration
Published: 2024

2. Adipose-Derived Stem Cell Exosomes Alleviate Psoriasis Serum Exosomes-Induced Inflammation by Regulating Autophagy and Redox Status in Keratinocytes

Author: Kim HR, Lee SY, You GE, Kim HO, Park CW, and Chung BY
Subjects: exosomes, adipose-derived stem cell, psoriasis, autophagy, oxidative stress, Dermatology, RL1-803
Abstract: Hye Ran Kim,1 So Yeon Lee,1 Ga Eun You,2 Hye One Kim,1 Chun Wook Park,1 Bo Young Chung1 1Department of Dermatology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, 07441, Korea; 2Research and Development Institute, Biosolution, Seoul Technopark, Seoul, 01811, KoreaCorrespondence: Bo Young Chung, Department of Dermatology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, 1 Singil-ro, Yeongdeungpo-gu, Seoul, 07441, Korea, Tel +82-2-829-5221, Fax +82-2-832-3237, Email victoryby@hallym.or.krIntroduction: Exosomes play a key role in cell communication and are involved in both pathological and physiological processes. Autophagy dysfunction and oxidative stress are linked to immune-mediated inflammatory diseases such as psoriasis. Stem cell-derived exosomes exhibit immunomodulatory and antioxidant efficacy.Methods: We aimed to investigate the impact of psoriasis serum-derived exosomes on inflammation, oxidative stress, and autophagy in keratinocytes. Additionally, we explored the therapeutic potential of adipose-derived stem cell (ADSC) exosomes against inflammation induced by psoriasis serum exosomes. To validate psoriasis patient serum-derived exosomes and ADSC exosomes, we used nanoparticle tracking analysis, Western blotting, flow cytometry, and immunofluorescence. qPCR was used to study changes in the gene expression of proinflammatory cytokines and oxidative stress markers in HaCaT cells treated with psoriasis serum-derived exosomes or ADSC exosomes. The effects of these exosomes on autophagy in HaCaT cells were evaluated by Western blotting and immunofluorescence.Result: The treatment of HaCaT cells with psoriasis serum-derived exosomes increased proinflammatory cytokine production and oxidative stress-related factor (Nox2 and Nox4) expression and decreased Nrf2 expression via P65/NF-κB and P38/MAPK activation. Compared with healthy control serum-derived exosomes, psoriasis serum-derived exosomes decreased ATG5, P62, Beclin1, and LC3 expression and autophagosome production in HaCaT cells. Conversely, ADSC exosomes suppressed proinflammatory cytokine and oxidative stress production, and restored autophagy in HaCaT cells treated with psoriasis serum-derived exosomes.Discussion: These findings suggest that ADSC exosomes exhibit a suppressive effect on psoriasis serum exosome-induced inflammation and oxidative stress by regulating autophagy in keratinocytes.Keywords: exosomes, adipose-derived stem cell, psoriasis, autophagy, oxidative stress
Published: 2023

3. Design and Optimization of Rivaroxaban-Cyclodextrin-Polymer Triple Complex Formulation with Improved Solubility

Author: Kang JH, Lee JE, Jeong SJ, Park CW, Kim DW, and Weon KY
Subjects: rivaroxaban, drug-cyclodextrin-polymer triple complex, solubilization, design of experiment, Therapeutics. Pharmacology, RM1-950
Abstract: Ji-Hyun Kang,1,&ast; Ji-Eun Lee,1,&ast; So-Jeong Jeong,1 Chun-Woong Park,1 Dong-Wook Kim,2 Kwon-Yeon Weon3 1College of Pharmacy, Chungbuk National University, Cheongju, Korea; 2College of Pharmacy, Wonkwang University, Iksan, Korea; 3College of Pharmacy, Daegu Catholic University, Gyeongsan, Korea&ast;These authors contributed equally to this workCorrespondence: Dong-Wook Kim, College of Pharmacy, Wonkwang University, Iksan, 54538, Korea, Tel +82-63-229-7130, Fax +82-63-850-7309, Email pharmengin@gmail.com Kwon-Yeon Weon, College of Pharmacy, Daegu Catholic University, Gyeongsan, 38430, Korea, Tel +82-53-850-3616, Fax +82-53-850-3602, Email weonky@cu.ac.krPurpose: This study aimed to ensure the convenience of administration and reproducibility of efficacy, regardless of the meal, by improving the solubility of rivaroxaban (RIV).Methods: RIV is a non-vitamin K antagonist oral anticoagulants that exhibits a coagulation effect by directly inhibiting coagulation factor Xa. However, RIV has a very low solubility; therefore, it must be administered with a meal at high doses. We used a drug- hydroxypropyl-beta-cyclodextrin (CD)-water-soluble polymer triple complex (R-C-P complex) to solubilize RIV. Using Minitab, we evaluated the effect of each factor on RIV solubility and developed an optimal R-C-P complex formulation. The amount of CD, amount of polymer, and polymer type were set as the independent variables X1, X2, and X3, respectively. RIV solubility (Y1) and dissolution rate for 45 min in pH 4.5 medium (Y2) and pH 1.2 medium (Y3) were set as response variables.Results: The most efficient RIV solubilization effect was obtained from the composition using CD and HPMC 2208, and physicochemical properties and dissolution parameters were analyzed. RIV in the R-C-P complex was present in an amorphous form and showed high solubility. Unlike commercial products, it showed a 100% dissolution rate. The R-C-P complex formulation secured high RIV solubility and 100% release regardless of pH.Conclusion: The results imply that high-dose RIV can be administered regardless of the meal, reducing the risk of changing the drug effect due to the patient’s administration mistake.Keywords: rivaroxaban, drug-cyclodextrin-polymer triple complex, solubilization, design of experiment
Published: 2022

4. Inhalable Nano-Dimpled Microspheres Containing Budesonide-PLGA for Improved Aerodynamic Performance

Author: Han CS, Kang JH, Kim YJ, Kim DW, and Park CW
Subjects: nanoscale dimple, aerodynamic performance, particle image velocimetry, computational fluid dynamics, Medicine (General), R5-920
Abstract: Chang-Soo Han,1,&ast; Ji-Hyun Kang,1,&ast; Young-Jin Kim,1 Dong-Wook Kim,2 Chun-Woong Park1 1College of Pharmacy, Chungbuk National University, Cheongju, 28160, Republic of Korea; 2College of Pharmacy, Wonkwang University, Iksan, 54538, Republic of Korea&ast;These authors contributed equally to this workCorrespondence: Chun-Woong Park, College of Pharmacy, Chungbuk National University, 194-21, Osongsangmyeong 1-ro, Heungdeok-gu, Cheongju, Chungbuk, 28160, Republic of Korea, Tel +82-43-261-3330, Fax +82-43-268-2732, Email cwpark@cbnu.ac.krIntroduction: Dry powder inhalations are an attractive pharmaceutical dosage form. They are environmentally friendly, portable, and physicochemical stable compared to other inhalation forms like pressurized metered-dose inhalers and nebulizers. Sufficient drug deposition of DPIs into the deep lung is required to enhance the therapeutic activity. Nanoscale surface roughness in microparticles could improve aerosolization and aerodynamic performance. This study aimed to prepare microspheres with nanoscale dimples and confirm the effect of roughness on inhalation efficiency.Methods: The dimpled-surface on microspheres (MSs) was achieved by oil in water (O/W) emulsion-solvent evaporation by controlling the stirring rate. The physicochemical properties of MSs were characterized. Also, in vitro aerodynamic performance of MSs was evaluated by particle image velocimetry and computational fluid dynamics.Results: The particle image velocimetry results showed that dimpled-surface MSs had better aerosolization, about 20% decreased X-axial velocity, and a variable angle, which could improve the aerodynamic performance. Furthermore, it was confirmed that the dimpled surface of MSs could cause movement away from the bronchial surface, which helps the MSs travel into the deep lung using computational fluid dynamics.Conclusion: The dimpled-surface MSs showed a higher fine particle fraction value compared to smooth-surface MSs in the Andersen Cascade Impactor, and surface roughness like dimples on microspheres could improve aerosolization and lung deposition.Keywords: nanoscale dimple, aerodynamic performance, particle image velocimetry, computational fluid dynamics
Published: 2022

5. Effects of Autophagy Modulators and Dioxin on the Expression of Epidermal Differentiation Proteins on Psoriasis-Like Keratinocytes in vitro and ex vivo

Author: Kim HR, Kim HO, Kim JC, Park CW, and Chung BY
Subjects: aryl hydrocarbon receptor, autophagy, keratinocyte differentiation, 8-tetrachlorodibenzo-p-dioxin, chloroquine, Dermatology, RL1-803
Abstract: Hye Ran Kim, Hye One Kim, Jin Cheol Kim, Chun Wook Park, Bo Young Chung Department of Dermatology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, 07441, Republic of KoreaCorrespondence: Bo Young Chung, Department of Dermatology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, 07441, Republic of Korea, Tel +82-2-829-9092, Fax +82-2-832-3237, Email victoryby777@gmail.comObjective: Psoriasis is a chronic inflammatory skin disorder associated with impairment of epidermal differentiation. Many signaling pathways, including those involved in aryl hydrocarbon receptor (AHR) and autophagy dysfunction, are reportedly associated with the pathogenesis of psoriasis. However, the discrete effects of dioxin via AHR activation or autophagy on the epidermal barrier remain unclear. In the current study, we evaluated the effects of autophagy modulators (chloroquine [CQ] and rapamycin) and the AHR agonist TCDD on the expression of epidermal barrier proteins in psoriasis-like keratinocytes and psoriasis lesional skin tissue culture.Methods: Polycytokine-stimulated human keratinocytes and psoriasis skin biopsies were treated with TCDD, CQ, or rapamycin, and the expression of keratinocyte differentiation-related factors, such as S100A7, S100A8, HRNR, IVL, FLG, and KRT10, was examined by Western blotting or quantitative-polymerase chain reaction.Results: TCDD upregulated S100A7 and S100A8 expression in polycytokine-stimulated HaCaT cells compared to that in unstimulated cells. CQ decreased HRNR, IVL, and KRT10 mRNA levels, while rapamycin increased HRNR, IVL, and KRT10 mRNA levels in HaCaT cells relative to that in unstimulated cells. Co-treatment with CQ reversed TCDD-induced elevation in FLG, HRNR, and IVL mRNA expression. In psoriasis skin tissue, TCDD induced the upregulation of HRNR, IVL, S100A7, and S100A8 compared with that in normal skin. In ex vivo cultures treated with CQ, IVL expression in psoriasis skin tissue was repressed compared to that in normal skin tissue.Conclusion: Our data suggest that autophagy modulation or AHR activation affects processes involved in epidermal differentiation and relates to the pathogenesis of chronic inflammatory skin diseases with skin barrier abnormalities such as psoriasis.Keywords: aryl hydrocarbon receptor, autophagy, keratinocyte differentiation, 2,3,7,8-tetrachlorodibenzo-p-dioxin, chloroquine
Published: 2022

6. Optimization and Pharmacokinetic Evaluation of Synergistic Fenbendazole and Rapamycin Co-Encapsulated in Methoxy Poly(Ethylene Glycol)-b-Poly(Caprolactone) Polymeric Micelles

Author: Shin HJ, Jo MJ, Jin IS, Park CW, Kim JS, and Shin DH
Subjects: combination therapy, drug interaction, cytotoxicity, biodistribution, bioavailability, Medicine (General), R5-920
Abstract: Hee Ji Shin,1,&ast; Min Jeong Jo,1,&ast; Ik Sup Jin,1 Chun-Woong Park,1 Jin-Seok Kim,2 Dae Hwan Shin1 1College of Pharmacy, Chungbuk National University, Cheongju, 28160, Republic of Korea; 2Drug Information Research Institute (DIRI), College of Pharmacy, Sookmyung Women’s University, Seoul, 04310, Republic of Korea&ast;These authors contributed equally to this workCorrespondence: Dae Hwan ShinCollege of Pharmacy, Chungbuk National University, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju, 28160, Republic of KoreaTel +82 43 261 2820Fax +82 43 268 2732Email dshin@chungbuk.ac.krPurpose: We aimed to develop a nanocarrier formulation incorporating fenbendazole (FEN) and rapamycin (RAPA) with strong efficacy against A549 cancer cells. As FEN and RAPA are poorly soluble in water, it is difficult to apply them clinically in vivo. Therefore, we attempted to resolve this problem by encapsulating these drugs in polymeric micelles.Methods: We evaluated drug synergy using the combination index (CI) values of various molar ratios of FEN and RAPA. We formed and tested micelles composed of different polymers. Moreover, we conducted cytotoxicity, stability, release, pharmacokinetic, and biodistribution studies to investigate the antitumor effects of FEN/RAPA-loaded mPEG-b-PCL micelles.Results: We selected mPEG-b-PCL-containing FEN and RAPA at a molar ratio of 1:2 because these particles were consistent in size and had high encapsulation efficiency (EE, %) and drug loading (DL, %) capacity. The in vitro cytotoxicity was assessed for various FEN, RAPA, and combined FEN/RAPA formulations. After long-term exposures, both the solutions and the micelles had similar efficacy against A549 cancer cells. The in vivo pharmacokinetic study revealed that FEN/RAPA-loaded mPEG-b-PCL micelles had a relatively higher area under the plasma concentration–time curve from 0 to 2 h (AUC0– 2 h) and 0 to 8 h (AUC0– 8 h) and plasma concentration at time zero (Co) than that of the FEN/RAPA solution. The in vivo biodistribution assay revealed that the IV injection of FEN/RAPA-loaded mPEG-b-PCL micelles resulted in lower pulmonary FEN concentration than the IV injection of the FEN/RAPA solution.Conclusion: When FEN and RAPA had a 1:2 molar ratio, they showed synergism. Additionally, using data from in vitro cytotoxicity, synergism between a 1:2 molar ratio of FEN and RAPA was observed in the micelle formulation. The FEN/RAPA-loaded mPEG-b-PCL micelle had enhanced bioavailability than the FEN/RAPA solution.Keywords: combination therapy, drug interaction, cytotoxicity, biodistribution, bioavailability
Published: 2021

7. Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution

Author: Kang JH, Chon J, Kim YI, Lee HJ, Oh DW, Lee HG, Han CS, Kim DW, and Park CW
Subjects: Tacrolimus, Thermosensitive, Solid lipid nanoparticle, FT-IR imaging, Atopic dermatitis, Dermal delivery, Medicine (General), R5-920
Abstract: Ji-Hyun Kang*,1 Jinmann Chon*,2 Young-Il Kim,1 Hyo-Jung Lee,1 Dong-Won Oh,1 Hong-Goo Lee,1 Chang-Soo Han,1 Dong-Wook Kim,3 Chun-Woong Park11College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea; 2School of Medicine, Kyung Hee University, Seoul, Republic of Korea; 3Department of Pharmaceutical Engineering, Cheongju University, Cheongju, Republic of Korea*These authors contributed equally to this workBackground: Tacrolimus (TCR), also known as FK-506, is a biopharmaceutics classification system (BCS) class II drug that is insoluble in water because of its high log P values. After dermal application, TCR remains in the stratum corneum and passes through the skin layers with difficulty.Purpose: The objectives of this study were to develop and evaluate solid lipid nanoparticles (SLNs) with thermosensitive properties to improve penetration and retention.Methods: We prepared TCR-loaded thermosensitive solid lipid nanoparticles (TCR-SLNs) with different types of surfactants on the shell of the particle, which conferred the advantages of enhancing skin permeation and distribution. We also characterized them from a physic point of view and performed in vitro and in vivo evaluations.Results: The TCR contained in the prepared TCR-SLN was in an amorphous state and entrapped in the particles with a high loading efficiency. The assessment of ex vivo skin penetration using excised rat dorsal skin showed that the TCR-SLNs penetrated to a deeper layer than the reference product (0.1% Protopic®). In addition, the in vivo skin penetration test demonstrated that TCR-SLNs delivered more drug into deeper skin layers than the reference product. FT-IR images also confirmed drug distribution of TCR-SLNs into deeper layers of the skin.Conclusion: These results revealed the potential application of thermosensitive SLNs for the delivery of difficult-to-permeate, poorly water-soluble drugs into deep skin layers.Keywords: tacrolimus, thermosensitive, solid lipid nanoparticle, FT-IR imaging, atopic dermatitis, dermal delivery
Published: 2019

8. Physicochemical properties and drug-release mechanisms of dual-release bilayer tablet containing mirabegron and fesoterodine fumarate

Author: Lee HG, Park YS, Jeong JH, Kwon YB, Shin DH, Kim JY, Rhee YS, Park ES, Kim DW, and Park CW
Subjects: Mirabegron, Fesoterodine fumarate, Swelling property, Erosion property, bi-layer tablet, FT-IR imaging, Therapeutics. Pharmacology, RM1-950
Abstract: Hong-Goo Lee,*,1 Yun-Sang Park,*,1 Jin-Hyuk Jeong,1 Yong-Bin Kwon,1 Dae Hwan Shin,1 Ju-Young Kim,2 Yun-Seok Rhee,3 Eun-Seok Park,4 Dong-Wook Kim,5 Chun-Woong Park11College of Pharmacy, Chungbuk National University, Cheongju 28160, South Korea; 2College of Pharmacy, Woosuk University, Wanju 55338, South Korea; 3College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju 52828, South Korea; 4School of Pharmacy, Sungkyunkwan University, Suwon 16419, South Korea; 5Department of Pharmaceutical Engineering, Cheongju University, Cheongju 28530, South Korea*These authors contributed equally to this workIntroduction: In this study, a dual release bi-layer tablet containing Fesoterodine fumarate (Fst) 5 mg and Mirabegron (Mrb) 50 mg was prepared to investigate the different release behavior of each drug in bilayer tablet. The bilayer tablet was prepared based on monolayer-tablet formulation of each drug.Methods: The optimized bi-layer tablet showed an in vitro dissolution profile similar to commercial reference tablets Toviaz and Betmiga, based on a satisfactory similarity factor. Drug-release kinetics of each drug in the bilayer tablet were evaluated based on dissolution profiles. Drug-release behavior was evaluated by observing the surface of each layer by scanning electron microscopy and measuring the changes in weight and volume of the tablet during dissolution. Drug transfer between each layer was also investigated by Fourier -transform infrared spectroscopic imaging by observing the cross-section of the bilayer tablet cut vertically during dissolution.Results: The release of Fst was well suited for the Higuchi model, and the release of Mrb was well suited for the Hixson-crowell model. Compared with dissolution rate of each monolayer tablet, that of Fst in the bilayer tablet was slightly reduced (5%), but the dissolution rate of Mrb in bilayer tablet was dramatically decreased (20%). Also, a drug-release study confirmed that polymer swelling was dominant in Fst layer compared with polymer erosion, and degradation was dominant in MRB layer. Fourier-transform infrared imaging and 3-D image reconstruction showed that drug transfer in the bilayer tablet correlates with the results of drug-release behavior.Conclusion: These findings are expected to provide scientific insights in the development of a dual-release bilayer drug-delivery system for Fst and Mrb.Keywords: mirabegron, fesoterodine fumarate, swelling property, erosion property, bilayer tablet, FT-IR imaging
Published: 2019

9. Preparation and in vitro/in vivo evaluation of PLGA microspheres containing norquetiapine for long-acting injection

Author: Park CW, Lee HJ, Oh DW, Kang JH, Han CS, and Kim DW
Subjects: Norquetiapine freebase, PLGA, Microspheres, Long-acting injection, Pharmacokinetics, Therapeutics. Pharmacology, RM1-950
Abstract: Chun-Woong Park,1 Hyo-Jung Lee,1 Dong-Won Oh,1 Ji-Hyun Kang,1 Chang-Soo Han,1 Dong-Wook Kim21College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea; 2Department of Pharmaceutical Engineering, Cheongju University, Cheongju, Republic of KoreaBackground: Norquetiapine (N-desalkyl quetiapine, NQ) is an active metabolite of quetiapine with stable pharmacokinetic and pharmacological properties. However, its short half-life is a drawback for clinical applications, and long-acting formulations are required. Purpose: The objectives of this study were to prepare improved entrapment efficiency NQ freebase microspheres by the solvent evaporation method with poly(d,l-lactic-co-glycolic acid) (PLGA) as a release modulator and to evaluate their physicochemical and in vitro/in vivo release properties.Methods: NQ freebase PLGA (1:5 w/w) formulations were prepared by the oil-in-water (o/w) emulsion–solvent evaporation method. A solution of the drug and PLGA in 9:1 v/v dichloromethane:ethanol was mixed with 0.2% polyvinyl alcohol and homogenized at 2,800 rpm. The emulsion was stirred for 3 h to dilute and evaporate the solvent. After that, the resulting product was freeze-dried. Drug-loading capacity was measured by the validated RP-HPLC method. The surface morphology of the microspheres was observed by scanning electron microscopy (SEM), and the physicochemical properties were evaluated by differential scanning calorimetry, powder X-ray diffraction, and Fourier-transform infrared spectroscopy particle size distribution. The in vitro dissolution test was performed using a rotary shaking bath at 37°C, with constant shaking at 50 rpm in sink condition. Results: The NQ freebase microspheres prepared by o/w emulsion-solvent evaporation showed over 30 % efficiency. NQ was confirmed to be amorphous in the microspheres by powder X-ray diffraction and differential scanning calorimetry. Special chemical interaction in the microspheres was not observed by FT-IR. The in vitro dissolution test demonstrated that the prepared microspheres' release properties were maintained for more than 20 days. The in vivo test is also confirmed that the particles' long acting of the particle were maintained. Therefore, good in vitro–in vivo correlation was established.Conclusion: In this study, NQ freebase-PLGA microspheres showed potential for the treatment of schizophrenia for long-periods.Keywords: schizophrenia, freebase, o/w emulsion-solvent evaporation, freeze dry, active metabolite, IVIVC
Published: 2018

10. Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

Author: Kim JY, Lee SH, Park CW, Rhee YS, Kim DW, Park J, Lee M, Seo JW, and Park ES
Subjects: Therapeutics. Pharmacology, RM1-950
Abstract: Ju-Young Kim,1,* Sung-Hoon Lee,2,3,* Chun-Woong Park,4 Yun-Seok Rhee,5 Dong-Wook Kim,6 Junsang Park,3 Moonseok Lee,3 Jeong-Woong Seo,2 Eun-Seok Park2 1College of Pharmacy, Woosuk University, Wanju-gun, Republic of Korea; 2School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea; 3GL Pharmtech, Seongnam, Republic of Korea; 4College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea; 5College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju, Republic of Korea; 6Department of Pharmaceutical Engineering, Cheongju University, Cheongju, Republic of Korea *These authors contributed equally to this work Abstract: The aim of present study was to design oxycodone once-a-day controlled-release (CR) tablets and to perform in vitro/in vivo characterizations. Release profiles to achieve desired plasma concentration versus time curves were established by using simulation software and reported pharmacokinetic parameters of the drug. Hydroxypropyl methylcellulose (HPMC) 100,000 mPa·s was used as a release modifier because the polymer was found to be resistant to changes in conditions of the release study, including rotation speed of paddle and ion strength. The burst release of the drug from the CR tablets could be suppressed by applying an additional HPMC layer as a physical barrier. Finally, the oxycodone once-a-day tablet was comprised of two layers, an inert HPMC layer and a CR layer containing drug and HPMC. Commercial products, either 10 mg bis in die (bid [twice a day]) or once-a-day CR tablets (20 mg) were administered to healthy volunteers, and calculated pharmacokinetic parameters indicated bioequivalence of the two different treatments. The findings of the present study emphasize the potential of oxycodone once-a-day CR tablets for improved patient compliance, safety, and efficacy, which could help researchers to develop new CR dosage forms of oxycodone. Keywords: pharmacokinetics, oral delivery, in vitro–in vivo correlation, double-layer tablet
Published: 2015

11. Recent advances and applications of deep learning methods in materials science

Author: Choudhary, K, Choudhary, K, DeCost, B, Chen, C, Jain, A, Tavazza, F, Cohn, R, Park, CW, Choudhary, A, Agrawal, A, Billinge, SJL, Holm, E, Ong, SP, Wolverton, C, Choudhary, K, Choudhary, K, DeCost, B, Chen, C, Jain, A, Tavazza, F, Cohn, R, Park, CW, Choudhary, A, Agrawal, A, Billinge, SJL, Holm, E, Ong, SP, and Wolverton, C
Abstract: Deep learning (DL) is one of the fastest-growing topics in materials data science, with rapidly emerging applications spanning atomistic, image-based, spectral, and textual data modalities. DL allows analysis of unstructured data and automated identification of features. The recent development of large materials databases has fueled the application of DL methods in atomistic prediction in particular. In contrast, advances in image and spectral data have largely leveraged synthetic data enabled by high-quality forward models as well as by generative unsupervised DL methods. In this article, we present a high-level overview of deep learning methods followed by a detailed discussion of recent developments of deep learning in atomistic simulation, materials imaging, spectral analysis, and natural language processing. For each modality we discuss applications involving both theoretical and experimental data, typical modeling approaches with their strengths and limitations, and relevant publicly available software and datasets. We conclude the review with a discussion of recent cross-cutting work related to uncertainty quantification in this field and a brief perspective on limitations, challenges, and potential growth areas for DL methods in materials science.
Published: 2022

12. Managerial Learning from Analyst Feedback to Voluntary Capex Guidance, Investment Efficiency and Firm Performance

Author: Bae, J, Biddle, G, Park, CW, Bae, J, Biddle, G, and Park, CW
Abstract: We test predictions that managers issuing voluntary capex guidance learn from analyst feedback and that this learning enhances investment efficiency and firm performance (Langberg and Sivaramakrishnan, 2010). Our findings are consistent with these predictions. First, we find that managers’ capex adjustments and capex guidance revisions relate positively with analyst feedback measured by differences between post-guidance analyst capex forecasts and managerial capex guidance. Second, changes in investment efficiency relate positively with analyst feedback. Third, subsequent firm financial performance relates positively with the predicted values of both managers’ capex adjustments and capex guidance revisions. These findings extend prior evidence regarding sources of managerial learning and investment efficiency and help to explain the active issuance of voluntary guidance by managers in settings where, as for capex guidance, the potential for managerial learning from related share price effects is limited.
Published: 2022

13. Effects of long-term exercise on memory recovery in the aged gerbil hippocampus after transient cerebral ischemia

Author: Park, CW, Cho, JH, Ohk, TG, Shin, MC, and Won, MH
Published: 2015
Full Text: View/download PDF

14. Hydroquinone shows neuroprotective potential in an experimental ischemic stroke model via attenuation of blood-brain barrier disruption

Author: Cho, JH, Park, CW, Ohk, TG, Shin, MC, and Won, MH
Published: 2015
Full Text: View/download PDF

15. Impact of hyperthermia before and during ischemia reperfusion on neuronal damage and gliosis in the gerbil hippocampus induced by transient cerebral ischemia

Author: Park, CW, Cho, JH, Ohk, TG, Shin, MC, and Won, MH
Published: 2015
Full Text: View/download PDF

16. Measurement of branching fraction and search for CP violation in B -> phi phi K

Author: Mohanty, S, Kaliyar, AB, Gaur, V, Mohanty, GB, Adachi, I, Adamczyk, K, Aihara, H, Said, SA, Asner, DM, Atmacan, H, Aulchenko, V, Aushev, T, Aziz, T, Babu, V, Bahinipati, S, Behera, P, Bessner, M, Bhardwaj, V, Bilka, T, Biswal, J, Bobrov, A, Bozek, A, Bracko, M, Browder, TE, Campajola, M, Cervenkov, D, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Cho, K, Cho, S-J, Choi, S-K, Choi, Y, Choudhury, S, Cinabro, D, Cunliffe, S, Das, S, Dash, N, De Nardo, G, Dhamija, R, Capua, FD, Dolezal, Z, Dong, T, Eidelman, S, Ferber, T, Fulsom, BG, Gabyshev, N, Garmash, A, Giri, A, Goldenzweig, P, Golob, B, Grzymkowska, O, Guan, Y, Gudkova, K, Hadjivasiliou, C, Halder, S, Hayasaka, K, Hayashii, H, Hou, W-S, Hsu, C-L, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, M, Jacobs, WW, Jeon, HB, Jia, S, Jin, Y, Joo, KK, Kang, KH, Karyan, G, Kim, BH, Kim, CH, Kim, DY, Kim, SH, Kim, Y-K, Kinoshita, K, Kodys, P, Konno, T, Korpar, S, Kotchetkov, D, Krizan, P, Krokovny, P, Kulasiri, R, Kumar, M, Kumar, R, Kumara, K, Kwon, Y-J, Lalwani, K, Lee, SC, Li, J, Li, LK, Li, YB, Gioi, LL, Libby, J, Liptak, Z, Liventsev, D, MacQueen, C, Masuda, M, Matsuda, T, Merola, M, Miyabayashi, K, Mizuk, R, Moon, TJ, Mussa, R, Nakao, M, Natochii, A, Nayak, L, Nayak, M, Nishida, S, Ogawa, K, Ogawa, S, Onuki, Y, Oskin, P, Pakhlova, G, Pardi, S, Park, CW, Park, H, Park, S-H, Patra, S, Pedlar, TK, Pestotnik, R, Piilonen, LE, Podobnik, T, Popov, V, Prencipe, E, Prim, MT, Rohrken, M, Rostomyan, A, Rout, N, Russo, G, Sahoo, D, Sakai, Y, Sandilya, S, Sangal, A, Sanuki, T, Savinov, V, Schnell, G, Schueler, J, Schwanda, C, Schwartz, AJ, Seino, Y, Senyo, K, Sevior, ME, Shapkin, M, Sharma, C, Shiu, J-G, Shwartz, B, Simon, F, Solovieva, E, Staric, M, Stottler, ZS, Strube, JF, Sumiyoshi, T, Takizawa, M, Tanida, K, Tao, Y, Tenchini, F, Uchida, M, Unno, Y, Uno, S, Usov, Y, Vahsen, SE, Van Tonder, R, Varner, G, Varvell, KE, Vinokurova, A, Vorobyev, V, Wang, CH, Wang, E, Wang, M-Z, Wang, P, Wang, XL, Watanuki, S, Wiechczynski, J, Won, E, Xu, X, Yabsley, BD, Yan, W, Ye, H, Yin, JH, Zhang, ZP, Zhilich, V, Zhukova, V, Mohanty, S, Kaliyar, AB, Gaur, V, Mohanty, GB, Adachi, I, Adamczyk, K, Aihara, H, Said, SA, Asner, DM, Atmacan, H, Aulchenko, V, Aushev, T, Aziz, T, Babu, V, Bahinipati, S, Behera, P, Bessner, M, Bhardwaj, V, Bilka, T, Biswal, J, Bobrov, A, Bozek, A, Bracko, M, Browder, TE, Campajola, M, Cervenkov, D, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Cho, K, Cho, S-J, Choi, S-K, Choi, Y, Choudhury, S, Cinabro, D, Cunliffe, S, Das, S, Dash, N, De Nardo, G, Dhamija, R, Capua, FD, Dolezal, Z, Dong, T, Eidelman, S, Ferber, T, Fulsom, BG, Gabyshev, N, Garmash, A, Giri, A, Goldenzweig, P, Golob, B, Grzymkowska, O, Guan, Y, Gudkova, K, Hadjivasiliou, C, Halder, S, Hayasaka, K, Hayashii, H, Hou, W-S, Hsu, C-L, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, M, Jacobs, WW, Jeon, HB, Jia, S, Jin, Y, Joo, KK, Kang, KH, Karyan, G, Kim, BH, Kim, CH, Kim, DY, Kim, SH, Kim, Y-K, Kinoshita, K, Kodys, P, Konno, T, Korpar, S, Kotchetkov, D, Krizan, P, Krokovny, P, Kulasiri, R, Kumar, M, Kumar, R, Kumara, K, Kwon, Y-J, Lalwani, K, Lee, SC, Li, J, Li, LK, Li, YB, Gioi, LL, Libby, J, Liptak, Z, Liventsev, D, MacQueen, C, Masuda, M, Matsuda, T, Merola, M, Miyabayashi, K, Mizuk, R, Moon, TJ, Mussa, R, Nakao, M, Natochii, A, Nayak, L, Nayak, M, Nishida, S, Ogawa, K, Ogawa, S, Onuki, Y, Oskin, P, Pakhlova, G, Pardi, S, Park, CW, Park, H, Park, S-H, Patra, S, Pedlar, TK, Pestotnik, R, Piilonen, LE, Podobnik, T, Popov, V, Prencipe, E, Prim, MT, Rohrken, M, Rostomyan, A, Rout, N, Russo, G, Sahoo, D, Sakai, Y, Sandilya, S, Sangal, A, Sanuki, T, Savinov, V, Schnell, G, Schueler, J, Schwanda, C, Schwartz, AJ, Seino, Y, Senyo, K, Sevior, ME, Shapkin, M, Sharma, C, Shiu, J-G, Shwartz, B, Simon, F, Solovieva, E, Staric, M, Stottler, ZS, Strube, JF, Sumiyoshi, T, Takizawa, M, Tanida, K, Tao, Y, Tenchini, F, Uchida, M, Unno, Y, Uno, S, Usov, Y, Vahsen, SE, Van Tonder, R, Varner, G, Varvell, KE, Vinokurova, A, Vorobyev, V, Wang, CH, Wang, E, Wang, M-Z, Wang, P, Wang, XL, Watanuki, S, Wiechczynski, J, Won, E, Xu, X, Yabsley, BD, Yan, W, Ye, H, Yin, JH, Zhang, ZP, Zhilich, V, and Zhukova, V
Published: 2021

17. Measurements of partial branching fractions of inclusive B -> XTI4PFTI4PF(u)(lx+)nu(l) decays with hadronic tagging

Author: Cao, L, Sutcliffe, W, Van Tonder, R, Bernlochner, FU, Adachi, I, Aihara, H, Al Said, S, Asner, DM, Atmacan, H, Aushev, T, Ayad, R, Babu, V, Bauer, M, Behera, P, Belous, K, Bennett, J, Bessner, M, Bhardwaj, V, Bilka, T, Biswal, J, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Campajola, M, Cervenkov, D, Chang, M-C, Chang, P, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Cho, HE, Cho, K, Cho, S-J, Choi, S-K, Choi, Y, Choudhury, S, Cinabro, D, Cunliffe, S, Das, S, Dash, N, De Nardo, G, Di Capua, F, Dingfelder, J, Dolezal, Z, Dong, T, Dubey, S, Eidelman, S, Epifanov, D, Ferber, T, Ferlewicz, D, Frey, A, Fulsom, BG, Garg, R, Gaur, V, Garmash, A, Giri, A, Goldenzweig, P, Guan, Y, Hadjivasiliou, C, Hara, T, Hartbrich, O, Hayasaka, K, Hayashii, H, Hedges, MT, Villanueva, MH, Hou, W-S, Hsu, C-L, Iijima, T, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, M, Iwasaki, Y, Jacobs, WW, Jang, E-J, Jeon, HB, Jia, S, Jin, Y, Joo, CW, Joo, KK, Kang, KH, Karyan, G, Kawasaki, T, Kichimi, H, Kiesling, C, Kim, BH, Kim, CH, Kim, DY, Kim, HJ, Kim, K-H, Kim, SH, Kim, Y-K, Kinoshita, K, Kodys, P, Konno, T, Korobov, A, Korpar, S, Kotchetkov, D, Kovalenko, E, Krizan, P, Kroeger, R, Krokovny, P, Kuhr, T, Kumar, M, Kumar, R, Kumara, K, Kuzmin, A, Kwon, Y-J, Lalwani, K, Lange, JS, Lee, IS, Lee, SC, Lewis, P, Li, CH, Li, J, Li, LK, Li, YB, Li Gioi, L, Libby, J, Lieret, K, Liptak, Z, Liventsev, D, MacNaughton, J, MacQueen, C, Masuda, M, Matsuda, T, Matvienko, D, Merola, M, Metzner, F, Miyabayashi, K, Mizuk, R, Mohanty, GB, Moon, TJ, Mori, T, Mrvar, M, Mussa, R, Nakao, M, Natkaniec, Z, Natochii, A, Nayak, L, Nayak, M, Niiyama, M, Nisar, NK, Nishida, S, Nishimura, K, Ogawa, S, Ono, H, Onuki, Y, Oskin, P, Pakhlov, P, Pakhlova, G, Pang, T, Pardi, S, Park, CW, Park, H, Park, S-H, Patra, S, Paul, S, Pedlar, TK, Pestotnik, R, Piilonen, LE, Podobnik, T, Popov, V, Prencipe, E, Prim, MT, Ritter, M, Rohrken, M, Rostomyan, A, Rout, N, Rozanska, M, Russo, G, Sahoo, D, Sakai, Y, Sandilya, S, Sangal, A, Santelj, L, Sanuki, T, Savinov, V, Schnell, G, Schueler, J, Schwanda, C, Schwartz, AJ, Seino, Y, Senyo, K, Sevior, ME, Shapkin, M, Sharma, C, Shen, CP, Shiu, J-G, Simon, F, Sokolov, A, Solovieva, E, Stanic, S, Staric, M, Stottler, ZS, Strube, JF, Sumiyoshi, T, Takizawa, M, Tamponi, U, Tanida, K, Tenchini, F, Trabelsi, K, Uchida, M, Uglov, T, Unno, Y, Uno, S, Urquijo, P, Usov, Y, Vahsen, SE, Varner, G, Varvell, KE, Vinokurova, A, Vorobyev, V, Vossen, A, Waheed, E, Wang, CH, Wang, E, Wang, M-Z, Wang, P, Watanabe, M, Watanuki, S, Wehle, S, Wiechczynski, J, Won, E, Xu, X, Yabsley, BD, Yan, W, Yang, SB, Ye, H, Yin, JH, Yuan, CZ, Yusa, Y, Zhang, ZP, Zhilich, V, Zhukova, V, Zhulanov, V, Cao, L, Sutcliffe, W, Van Tonder, R, Bernlochner, FU, Adachi, I, Aihara, H, Al Said, S, Asner, DM, Atmacan, H, Aushev, T, Ayad, R, Babu, V, Bauer, M, Behera, P, Belous, K, Bennett, J, Bessner, M, Bhardwaj, V, Bilka, T, Biswal, J, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Campajola, M, Cervenkov, D, Chang, M-C, Chang, P, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Cho, HE, Cho, K, Cho, S-J, Choi, S-K, Choi, Y, Choudhury, S, Cinabro, D, Cunliffe, S, Das, S, Dash, N, De Nardo, G, Di Capua, F, Dingfelder, J, Dolezal, Z, Dong, T, Dubey, S, Eidelman, S, Epifanov, D, Ferber, T, Ferlewicz, D, Frey, A, Fulsom, BG, Garg, R, Gaur, V, Garmash, A, Giri, A, Goldenzweig, P, Guan, Y, Hadjivasiliou, C, Hara, T, Hartbrich, O, Hayasaka, K, Hayashii, H, Hedges, MT, Villanueva, MH, Hou, W-S, Hsu, C-L, Iijima, T, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, M, Iwasaki, Y, Jacobs, WW, Jang, E-J, Jeon, HB, Jia, S, Jin, Y, Joo, CW, Joo, KK, Kang, KH, Karyan, G, Kawasaki, T, Kichimi, H, Kiesling, C, Kim, BH, Kim, CH, Kim, DY, Kim, HJ, Kim, K-H, Kim, SH, Kim, Y-K, Kinoshita, K, Kodys, P, Konno, T, Korobov, A, Korpar, S, Kotchetkov, D, Kovalenko, E, Krizan, P, Kroeger, R, Krokovny, P, Kuhr, T, Kumar, M, Kumar, R, Kumara, K, Kuzmin, A, Kwon, Y-J, Lalwani, K, Lange, JS, Lee, IS, Lee, SC, Lewis, P, Li, CH, Li, J, Li, LK, Li, YB, Li Gioi, L, Libby, J, Lieret, K, Liptak, Z, Liventsev, D, MacNaughton, J, MacQueen, C, Masuda, M, Matsuda, T, Matvienko, D, Merola, M, Metzner, F, Miyabayashi, K, Mizuk, R, Mohanty, GB, Moon, TJ, Mori, T, Mrvar, M, Mussa, R, Nakao, M, Natkaniec, Z, Natochii, A, Nayak, L, Nayak, M, Niiyama, M, Nisar, NK, Nishida, S, Nishimura, K, Ogawa, S, Ono, H, Onuki, Y, Oskin, P, Pakhlov, P, Pakhlova, G, Pang, T, Pardi, S, Park, CW, Park, H, Park, S-H, Patra, S, Paul, S, Pedlar, TK, Pestotnik, R, Piilonen, LE, Podobnik, T, Popov, V, Prencipe, E, Prim, MT, Ritter, M, Rohrken, M, Rostomyan, A, Rout, N, Rozanska, M, Russo, G, Sahoo, D, Sakai, Y, Sandilya, S, Sangal, A, Santelj, L, Sanuki, T, Savinov, V, Schnell, G, Schueler, J, Schwanda, C, Schwartz, AJ, Seino, Y, Senyo, K, Sevior, ME, Shapkin, M, Sharma, C, Shen, CP, Shiu, J-G, Simon, F, Sokolov, A, Solovieva, E, Stanic, S, Staric, M, Stottler, ZS, Strube, JF, Sumiyoshi, T, Takizawa, M, Tamponi, U, Tanida, K, Tenchini, F, Trabelsi, K, Uchida, M, Uglov, T, Unno, Y, Uno, S, Urquijo, P, Usov, Y, Vahsen, SE, Varner, G, Varvell, KE, Vinokurova, A, Vorobyev, V, Vossen, A, Waheed, E, Wang, CH, Wang, E, Wang, M-Z, Wang, P, Watanabe, M, Watanuki, S, Wehle, S, Wiechczynski, J, Won, E, Xu, X, Yabsley, BD, Yan, W, Yang, SB, Ye, H, Yin, JH, Yuan, CZ, Yusa, Y, Zhang, ZP, Zhilich, V, Zhukova, V, and Zhulanov, V
Published: 2021

18. Search for lepton-number- and baryon-number-violating tau decays at Belle

Author: Sahoo, D, Mohanty, GB, Trabelsi, K, Adachi, I, Adamczyk, K, Aihara, H, Al Said, S, Asner, DM, Aushev, T, Ayad, R, Aziz, T, Babu, V, Bahinipati, S, Behera, P, Bennett, J, Bessner, M, Bhardwaj, V, Bilka, T, Biswal, J, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Campajola, M, Cao, L, Cervenkov, DT, Chang, M-C, Chang, P, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Cho, HE, Cho, K, Choi, S-K, Choi, Y, Choudhury, S, Cinabro, D, Cunliffe, S, Das, S, Dash, N, De Nardo, G, Di Capua, F, Dingfelder, J, Dolezal, Z, Dong, T, Dubey, S, Eidelman, S, Epifanov, D, Ferber, T, Ferlewicz, D, Frey, A, Fulsom, BG, Garg, R, Gaur, V, Garmash, A, Giri, A, Goldenzweig, P, Golob, B, Guan, Y, Gudkova, K, Hadjivasiliou, C, Halder, S, Hara, T, Hartbrich, O, Hayasaka, K, Hayashii, H, Hedges, MT, Villanueva, MH, Hou, W-S, Hsu, C-L, Huang, K, Iijima, T, Inami, K, Inguglia, G, Ishikawa, A, Itoh, R, Iwasaki, M, Iwasaki, Y, Jacobs, WW, Jeon, HB, Jia, S, Jin, Y, Joo, CW, Joo, KK, Kaliyar, AB, Kang, KH, Karyan, G, Kawasaki, T, Kichimi, H, Kiesling, C, Kim, DY, Kim, SH, Kim, Y-K, Kinoshita, K, Kodys, P, Konno, T, Korpar, S, Kotchetkov, D, Krizan, P, Kroeger, R, Krokovny, P, Kuhr, T, Kumar, M, Kumar, R, Kumara, K, Kuzmin, A, Kwon, Y-J, Lalwani, K, Lee, IS, Lee, SC, Li, CH, Li, J, Li, LK, Li, YB, Libby, J, Lieret, K, Liventsev, D, Luo, T, MacNaughton, J, Masuda, M, Matsuda, T, Matvienko, D, Merola, M, Metzner, F, Miyabayashi, K, Mizuk, R, Mohanty, S, Moon, TJ, Mussa, R, Nakano, E, Nakao, M, Natkaniec, Z, Natochii, A, Nayak, L, Nayak, M, Niiyama, M, Nisar, NK, Nishida, S, Ogawa, S, Ono, H, Onuki, Y, Oskin, P, Pakhlov, P, Pakhlova, G, Pang, T, Pardi, S, Park, CW, Park, H, Patra, S, Paul, S, Pedlar, TK, Pestotnik, R, Piilonen, LE, Podobnik, T, Popov, V, Prencipe, E, Prim, MT, Ritter, M, Rohrken, M, Rostomyan, A, Rout, N, Rozanska, M, Russo, G, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Savinov, V, Schnell, G, Schueler, J, Schwanda, C, Schwartz, AJ, Seino, Y, Senyo, K, Sevior, ME, Shapkin, M, Sharma, C, Shen, CP, Shiu, J-G, Shwartz, B, Simon, F, Sokolov, A, Solovieva, E, Stanic, S, Staric, M, Stottler, ZS, Strube, JF, Sumiyoshi, T, Takizawa, M, Tamponi, U, Tanida, K, Tenchini, F, Uchida, M, Uehara, S, Uglov, T, Unno, Y, Uno, S, Urquijo, P, Ushiroda, Y, Vahsen, SE, Van Tonder, R, Varner, G, Vinokurova, A, Vorobyev, V, Waheed, E, Wang, CH, Wang, E, Wang, M-Z, Wang, P, Watanabe, M, Watanuki, S, Wehle, S, Won, E, Xu, X, Yabsley, BD, Yan, W, Yang, SB, Ye, H, Yelton, J, Yin, JH, Yusa, Y, Zhilich, V, Zhukova, V, Zhulanov, V, Sahoo, D, Mohanty, GB, Trabelsi, K, Adachi, I, Adamczyk, K, Aihara, H, Al Said, S, Asner, DM, Aushev, T, Ayad, R, Aziz, T, Babu, V, Bahinipati, S, Behera, P, Bennett, J, Bessner, M, Bhardwaj, V, Bilka, T, Biswal, J, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Campajola, M, Cao, L, Cervenkov, DT, Chang, M-C, Chang, P, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Cho, HE, Cho, K, Choi, S-K, Choi, Y, Choudhury, S, Cinabro, D, Cunliffe, S, Das, S, Dash, N, De Nardo, G, Di Capua, F, Dingfelder, J, Dolezal, Z, Dong, T, Dubey, S, Eidelman, S, Epifanov, D, Ferber, T, Ferlewicz, D, Frey, A, Fulsom, BG, Garg, R, Gaur, V, Garmash, A, Giri, A, Goldenzweig, P, Golob, B, Guan, Y, Gudkova, K, Hadjivasiliou, C, Halder, S, Hara, T, Hartbrich, O, Hayasaka, K, Hayashii, H, Hedges, MT, Villanueva, MH, Hou, W-S, Hsu, C-L, Huang, K, Iijima, T, Inami, K, Inguglia, G, Ishikawa, A, Itoh, R, Iwasaki, M, Iwasaki, Y, Jacobs, WW, Jeon, HB, Jia, S, Jin, Y, Joo, CW, Joo, KK, Kaliyar, AB, Kang, KH, Karyan, G, Kawasaki, T, Kichimi, H, Kiesling, C, Kim, DY, Kim, SH, Kim, Y-K, Kinoshita, K, Kodys, P, Konno, T, Korpar, S, Kotchetkov, D, Krizan, P, Kroeger, R, Krokovny, P, Kuhr, T, Kumar, M, Kumar, R, Kumara, K, Kuzmin, A, Kwon, Y-J, Lalwani, K, Lee, IS, Lee, SC, Li, CH, Li, J, Li, LK, Li, YB, Libby, J, Lieret, K, Liventsev, D, Luo, T, MacNaughton, J, Masuda, M, Matsuda, T, Matvienko, D, Merola, M, Metzner, F, Miyabayashi, K, Mizuk, R, Mohanty, S, Moon, TJ, Mussa, R, Nakano, E, Nakao, M, Natkaniec, Z, Natochii, A, Nayak, L, Nayak, M, Niiyama, M, Nisar, NK, Nishida, S, Ogawa, S, Ono, H, Onuki, Y, Oskin, P, Pakhlov, P, Pakhlova, G, Pang, T, Pardi, S, Park, CW, Park, H, Patra, S, Paul, S, Pedlar, TK, Pestotnik, R, Piilonen, LE, Podobnik, T, Popov, V, Prencipe, E, Prim, MT, Ritter, M, Rohrken, M, Rostomyan, A, Rout, N, Rozanska, M, Russo, G, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Savinov, V, Schnell, G, Schueler, J, Schwanda, C, Schwartz, AJ, Seino, Y, Senyo, K, Sevior, ME, Shapkin, M, Sharma, C, Shen, CP, Shiu, J-G, Shwartz, B, Simon, F, Sokolov, A, Solovieva, E, Stanic, S, Staric, M, Stottler, ZS, Strube, JF, Sumiyoshi, T, Takizawa, M, Tamponi, U, Tanida, K, Tenchini, F, Uchida, M, Uehara, S, Uglov, T, Unno, Y, Uno, S, Urquijo, P, Ushiroda, Y, Vahsen, SE, Van Tonder, R, Varner, G, Vinokurova, A, Vorobyev, V, Waheed, E, Wang, CH, Wang, E, Wang, M-Z, Wang, P, Watanabe, M, Watanuki, S, Wehle, S, Won, E, Xu, X, Yabsley, BD, Yan, W, Yang, SB, Ye, H, Yelton, J, Yin, JH, Yusa, Y, Zhilich, V, Zhukova, V, and Zhulanov, V
Published: 2020

19. Study of B -> p<(p)over bar>pi pi

Author: Chu, K, Wang, MZ, Adachi, I, Aihara, H, Al Said, S, Asner, DM, Aulchenko, V, Aushev, T, Ayad, R, Babu, V, Badhrees, I, Bahinipati, S, Bakich, AM, Behera, P, Beleno, C, Bennett, J, Bhardwaj, V, Bhuyan, B, Biswal, J, Bobrov, A, Bonvicini, G, Bozek, A, Bracko, M, Campajola, M, Cao, L, Cervenkov, D, Chang, P, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Cho, HE, Cho, K, Choi, SK, Choi, Y, Choudhury, S, Cinabro, D, Cunliffe, S, Dash, N, Di Capua, F, Di Carlo, S, Dolezal, Z, Dong, T, Eidelman, S, Epifanov, D, Fast, JE, Ferber, T, Frey, A, Fulsom, BG, Garg, R, Gaur, V, Gabyshev, N, Garmash, A, Giri, A, Goldenzweig, P, Golob, B, Hartbrich, O, Hayasaka, K, Hayashii, H, Hou, WS, Hsu, CL, Iijima, T, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, M, Iwasaki, Y, Jacobs, WW, Jeon, HB, Jin, Y, Joffe, D, Joo, KK, Karyan, G, Kawasaki, T, Kim, DY, Kim, SH, Kinoshita, K, Kodys, P, Korpar, S, Krizan, P, Kroeger, R, Krokovny, P, Kulasiri, R, Kwon, YJ, Lai, YT, Lee, IS, Lee, SC, Li, LK, Li Gioi, L, Libby, J, Lieret, K, Liventsev, D, Luo, T, Masuda, M, Matvienko, D, Merola, M, Miyabayashi, K, Mizuk, R, Mohanty, GB, Mori, T, Mussa, R, Nakano, E, Nakano, T, Nakao, M, Nath, KJ, Nayak, M, Nisar, NK, Nishida, S, Nishimura, K, Ono, H, Onuki, Y, Oskin, P, Pakhlov, P, Pakhlova, G, Pal, B, Pang, T, Pardi, S, Park, CW, Park, H, Park, SH, Paul, S, Pedlar, TK, Pestotnik, R, Piilonen, LE, Popov, V, Prencipe, E, Prim, MT, Resmi, PK, Ritter, M, Rostomyan, A, Rout, N, Russo, G, Sahoo, D, Sakai, Y, Sandilya, S, Santelj, L, Savinov, V, Schneider, O, Schnell, G, Schueler, J, Schwanda, C, Seino, Y, Senyo, K, Sevior, ME, Shen, CP, Shiu, JG, Solovieva, E, Staric, M, Stottler, ZS, Sumiyoshi, T, Sutcliffe, W, Takizawa, M, Tamponi, U, Tanida, K, Tenchini, F, Uglov, T, Unno, Y, Uno, S, Urquijo, P, Usov, Y, Varner, G, Vinokurova, A, Vossen, A, Wang, B, Wang, CH, Wang, P, Wang, XL, Wiechczynski, J, Won, E, Yang, SB, Ye, H, Yelton, J, Yin, JH, Yusa, Y, Zhang, ZP, Zhilich, V, Zhukova, V, Zhulanov, V, Chu, K, Wang, MZ, Adachi, I, Aihara, H, Al Said, S, Asner, DM, Aulchenko, V, Aushev, T, Ayad, R, Babu, V, Badhrees, I, Bahinipati, S, Bakich, AM, Behera, P, Beleno, C, Bennett, J, Bhardwaj, V, Bhuyan, B, Biswal, J, Bobrov, A, Bonvicini, G, Bozek, A, Bracko, M, Campajola, M, Cao, L, Cervenkov, D, Chang, P, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Cho, HE, Cho, K, Choi, SK, Choi, Y, Choudhury, S, Cinabro, D, Cunliffe, S, Dash, N, Di Capua, F, Di Carlo, S, Dolezal, Z, Dong, T, Eidelman, S, Epifanov, D, Fast, JE, Ferber, T, Frey, A, Fulsom, BG, Garg, R, Gaur, V, Gabyshev, N, Garmash, A, Giri, A, Goldenzweig, P, Golob, B, Hartbrich, O, Hayasaka, K, Hayashii, H, Hou, WS, Hsu, CL, Iijima, T, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, M, Iwasaki, Y, Jacobs, WW, Jeon, HB, Jin, Y, Joffe, D, Joo, KK, Karyan, G, Kawasaki, T, Kim, DY, Kim, SH, Kinoshita, K, Kodys, P, Korpar, S, Krizan, P, Kroeger, R, Krokovny, P, Kulasiri, R, Kwon, YJ, Lai, YT, Lee, IS, Lee, SC, Li, LK, Li Gioi, L, Libby, J, Lieret, K, Liventsev, D, Luo, T, Masuda, M, Matvienko, D, Merola, M, Miyabayashi, K, Mizuk, R, Mohanty, GB, Mori, T, Mussa, R, Nakano, E, Nakano, T, Nakao, M, Nath, KJ, Nayak, M, Nisar, NK, Nishida, S, Nishimura, K, Ono, H, Onuki, Y, Oskin, P, Pakhlov, P, Pakhlova, G, Pal, B, Pang, T, Pardi, S, Park, CW, Park, H, Park, SH, Paul, S, Pedlar, TK, Pestotnik, R, Piilonen, LE, Popov, V, Prencipe, E, Prim, MT, Resmi, PK, Ritter, M, Rostomyan, A, Rout, N, Russo, G, Sahoo, D, Sakai, Y, Sandilya, S, Santelj, L, Savinov, V, Schneider, O, Schnell, G, Schueler, J, Schwanda, C, Seino, Y, Senyo, K, Sevior, ME, Shen, CP, Shiu, JG, Solovieva, E, Staric, M, Stottler, ZS, Sumiyoshi, T, Sutcliffe, W, Takizawa, M, Tamponi, U, Tanida, K, Tenchini, F, Uglov, T, Unno, Y, Uno, S, Urquijo, P, Usov, Y, Varner, G, Vinokurova, A, Vossen, A, Wang, B, Wang, CH, Wang, P, Wang, XL, Wiechczynski, J, Won, E, Yang, SB, Ye, H, Yelton, J, Yin, JH, Yusa, Y, Zhang, ZP, Zhilich, V, Zhukova, V, and Zhulanov, V
Published: 2020

20. Effect of transient cerebral ischemia on the expression of receptor for advanced glycation end products in the gerbil hippocampus proper

Author: Cho, JH, Park, CW, Lee, HY, Won, MH, Lee, JY, and Chung, DJ
Published: 2014
Full Text: View/download PDF

21. Abdominal wall hernia during peritoneal dialysis

Author: Chung, S, Chang, YS, and Park, CW
Published: 2010

22. Ischemic preconditioning induces neuroprotection cause by a transient global ischemia via maintaining the expression of p63

Author: Cho, JH, Park, CW, Ohk, TG, Shin, MC, Kim, YS, and Won, MH
Published: 2015
Full Text: View/download PDF

23. Ischemic preconditioning maintains immunoreactivities of glucokinase and glucokinase regulatory protein in neurons of the gerbil hippocampal CA1 region following transient cerebral ischemia

Author: Cho, JH, Park, CW, Ohk, TG, Shin, MC, Kim, YS, and Won, MH
Published: 2015
Full Text: View/download PDF

24. Neuroprotective effects of novel antiepileptic drug lacosamide via decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke

Author: Cho, JH, Park, CW, Ohk, TG, Shin, MC, Kim, YS, and Won, MH
Published: 2015
Full Text: View/download PDF

25. Differences of calcium binding protein immunoreactivities in the young hippocampal CA1 region from the adult following transient ischemic damage

Author: Park, CW, Lee, HY, Cho, JH, and Won, MH
Published: 2013
Full Text: View/download PDF

26. Neuroprotective effect of a new synthetic aspirin-decursinol adduct in a rat model of ischemic stroke

Author: Lee, YH, Park, CW, Cho, JH, and Won, MH
Published: 2013
Full Text: View/download PDF

27. Changes of ribosomal protein S3 immunoreactivity and its new expression in microglia in the mice hippocampus after lipopolysaccharide treatment

Author: Cho, JH, Park, CW, Lee, HY, and Won, MH
Published: 2012
Full Text: View/download PDF

28. Neuronal damage using Fluoro-Jade B histofluorescence and gliosis in the striatum after various durations of transient cerebral ischemia in gerbils

Author: Cho, JH, Park, CW, Lee, HY, and Won, MH
Published: 2012
Full Text: View/download PDF

29. Facile Large Scale Production of Few-Layer Graphene Sheets by Shear Exfoliation in Volatile Solvent

Author: Kim Ys, Kim Js, Akhtar Mw, and Park Cw
Subjects: Materials science, Graphene, Atomic force microscopy, Biomedical Engineering, Bioengineering, General Chemistry, Condensed Matter Physics, law.invention, Solvent, Shear (sheet metal), symbols.namesake, Few layer graphene, law, symbols, General Materials Science, Graphite, Composite material, Thin film, Raman spectroscopy
Abstract: Few layer graphene sheets were synthesized from natural graphite through mechanical shear mixer in 1-butanol as solvent. The liquid phase exfoliation of graphite through the shear mixer generated incising forces for 20 minutes which changed the large amount of graphite's flake into few layer graphene. The removal of solvent from the deposited dispersion was performed immediately by keeping at the room temperature. The deposited graphene thin films were characterized by AFM, HR-TEM, XRD, FT-IR and Raman Spectroscopy. The HR-TEM results showed the formation of few layers and well dispersed graphene. The Raman spectroscopy and XRD characterization confirmed the good quality and non-oxidized state of graphene.
Published: 2015

30. Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation

Author: Seung-Hwan Shin, Min Ws, Ye Won Jeon, Cho Bs, Chang-Ki Min, Ki-Sung Eom, Sung Hyun Lee, Ji-Il Kim, Seok-Goo Cho, Seong-Beom Lee, Hyung-Ok Kim, Kim Yj, Junguee Lee, Park Cw, and Joo Hee Yoon
Subjects: Adult, Male, Oncology, medicine.medical_specialty, Myeloid, Adolescent, medicine.medical_treatment, Antineoplastic Agents, Translocation, Genetic, Cytogenetics, Young Adult, Recurrence, Risk Factors, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Aged, Retrospective Studies, Aged, 80 and over, Transplantation, Chemotherapy, business.industry, Core Binding Factors, Remission Induction, Induction chemotherapy, Retrospective cohort study, Hematology, Middle Aged, Prognosis, medicine.disease, Leukemia, Myeloid, Acute, Leukemia, Treatment Outcome, medicine.anatomical_structure, Graft-versus-host disease, Chromosome Inversion, Multivariate Analysis, Mutation, Immunology, Female, business, Trisomy
Abstract: Emerging molecular studies have identified a subgroup of patients with unfavorable core-binding factor-positive (CBF)-AML who should be treated by intensified post-remission treatments. We analyzed 264 adults with CBF-AML from 2002 to 2011, and focused on 206 patients who achieved CR after standard '3+7' induction chemotherapy. Patients who achieved CR with an available donor were treated with allogeneic hematopoietic SCT (allo-HSCT, n=115) and the rest were treated with autologous (auto) HSCT (n=72) or chemotherapy alone (n=19). OS was not significantly different between CBFβ/MYH11 (n=62) and RUNX1/RUNX1T1 (n=144), and auto-HSCT showed favorable OS compared with allo-HSCT or chemotherapy alone. Cytogenetic analysis identified that inv(16) without trisomy had a favorable OS and t(8;21) with additional chromosomes had an unfavorable OS, but multivariate analysis revealed those were NS. Patients with c-kit mutation showed inferior OS. For transplanted patients, residual post-transplant CBF-minimal residual disease quantitative PCR with higher WT1 expression at D+60 showed the worst OS with a higher incidence of relapse. Conclusively, we found that unfavorable CBF-AML can be defined with risk stratification using cytogenetic and molecular studies, and a careful risk-adapted treatment approach using frontline transplantation with novel therapies should be evaluated for this particular risk subgroup.
Published: 2014

31. PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL

Author: Jae-Ho Yoon, Ki-Sung Eom, Junguee Lee, Dong-Kee Kim, Min Ws, Sung Hyun Lee, Seung-Hwan Shin, Chang-Ki Min, Kim Yj, Seok-Goo Cho, Sung-Eun Lee, Park Cw, Cho Bs, Hyung-Ok Kim, and Seung-Ah Yahng
Subjects: Adult, Male, medicine.medical_specialty, Transplantation Conditioning, Adolescent, Graft vs Host Disease, Myeloablative Agonist, Therapeutics, Gastroenterology, Disease-Free Survival, Young Adult, Risk Factors, Unrelated Donor, Internal medicine, Republic of Korea, medicine, Humans, Young adult, Bone Marrow Transplantation, Retrospective Studies, Peripheral Blood Stem Cell Transplantation, Transplantation, business.industry, Myeloablative conditioning, Incidence (epidemiology), Retrospective cohort study, Hematology, Middle Aged, Myeloablative Agonists, Precursor Cell Lymphoblastic Leukemia-Lymphoma, surgical procedures, operative, Female, Unrelated Donors, business
Abstract: Few studies are available that compare PBSC and BM from unrelated donors, especially in adult high-risk ALL. To determine which graft source is superior in adult high-risk ALL, we analyzed the long-term outcomes of 106 consecutive transplants from 8/8-matched or 7/8-matched unrelated donors (38 PBSC vs 68 BM). All patients received a uniform strategy of pre-transplant therapy, myeloablative conditioning and GVHD prophylaxis. At 5 years, PBSC transplants showed higher incidence of chronic GVHD than did BM transplants (74.3% vs 46.7%, P=0.001). PBSC transplants showed outcomes comparable to those of BM transplants for relapse (23.7% vs 28.1%), non-relapse mortality (18.4% vs 25.0%), disease-free survival (57.9% vs 46.9%) and OS (57.9% vs 50.0%). In a separate comparison of outcomes between the two graft sources according to the presence of a Ph chromosome, no significant advantage of PBSC over BM was found in both subgroups of patients. Our data suggest that the outcomes of unrelated donor transplantation are similar between PBSC and BM in adult high-risk ALL. Whether PBSC should be the preferred graft source for a specific subgroup of adult ALL needs to be further investigated.
Published: 2014

32. Activation of the intracellular Ca++-AMPK pathway ameliorates apoptosis and improves autophagy in diabetic peripheral neuropathy

Author: Young Jin Ko, Park Cw, Hee-Youl Kim, and Jeongmi Park
Subjects: medicine.medical_specialty, Cinacalcet, biology, business.industry, Rehabilitation, Motor nerve, AMPK, biology.organism_classification, medicine.disease, Myelin, Endocrinology, medicine.anatomical_structure, Peripheral neuropathy, Apoptosis, Enos, Internal medicine, Medicine, Orthopedics and Sports Medicine, Sciatic nerve, business, medicine.drug
Abstract: Introduction/Background A decrement of AMP-activated protein kinase-eNOS bioavailability is critical for the pathogenesis of diabetic peripheral neuropathy. We evaluated the neuro-protective effect of cinacalcet on DPN by activating the AMPK-eNOS pathway using db/db mice. Material and method The db/db mice and db/m controls at 8 weeks of age were divided to receive either a regular diet or a diet containing cinacalcet. Mice were evaluated sciatic motor nerve conduction and tactile response. We performed Mason's trichrome staining and immunohistochemistry for type IV collagen and 8-hydroxy-deoxyguanosine, an oxidative DNA damage marker. For immunofluorescence double staining, apoptosis was detected by ApopTag Fluorescein In Situ Apoptosis Detection Kit. The sciatic nerve specimens were double stained and we measured unmyelinated fiber areas and axonal areas using NIH Image J under a transmission electron microscope. Western blot assay was performed total protein of sciatic nerve with specific antibodies for CaSR, CaMKK, total LKB1, phospho-Ser428 LKB1, total AMPK, phospho-Thr172 AMPK, total eNOS, phospho-Ser1177 eNOS, PGC-1. Results The db/db mice showed sensorimotor impairment, nerve fibrosis and inflammation, apoptosis, disorganized myelin with axonal shrinkage and degeneration, and fewer unmyelinated fibers in the sciatic nerve compared to db/m mice. Cinacalcet administration, without causing any changes in blood glucose and Ca++ concentrations, significantly increased the paw withdrawal mechanical threshold and decreased the motor conduction latency, and ameliorated the deterioration of sciatic nerve pathology, accompanied by increases in the expressions of calcium-sensing receptor-CaMKK and phosphorylation of AMPK-eNOS in diabetic mice. Conclusion Cinacalcet may play an important role in the prevention and amelioration of DPN by amplifying AMPK signaling.
Published: 2018

33. Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure

Author: Sung Hyun Lee, Sung-Eun Lee, Park Cw, Dong-Kee Kim, Ki-Sung Eom, Chang-Ki Min, Seung-Ah Yahng, Junguee Lee, Seung-Hwan Shin, Hyung-Ok Kim, Seok-Goo Cho, Cho Bs, Jae-Ho Yoon, Min Ws, and Kim Yj
Subjects: Adult, Male, Oncology, Antimetabolites, Antineoplastic, medicine.medical_specialty, Myeloid, Adolescent, medicine.medical_treatment, Young Adult, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Treatment Failure, Young adult, Survival rate, Aged, Aged, 80 and over, Transplantation, Chemotherapy, Performance status, business.industry, Hematopoietic Stem Cell Transplantation, Cancer, Hematology, Middle Aged, Prognosis, medicine.disease, Survival Rate, Leukemia, Myeloid, Acute, Leukemia, Treatment Outcome, medicine.anatomical_structure, Myelodysplastic Syndromes, Female, business
Abstract: The prognosis for patients with myelodysplastic syndrome with hypomethylating treatment failure (MDS-HTF) has been known to be poor. However, the clinical outcomes and optimal treatment options for secondary AML evolving from MDS-HTF (sAML/MDS-HTF) are not well known. This retrospective analysis was conducted to evaluate the clinical outcomes and influences of treatment options on survival in 46 consecutive patients with sAML/MDS-HTF. The median OS rates were 1.4 months in the best supportive care group (n=15) and 9.4 months in the active treatment group (n=31). One-year OS rates were 13.3% and 36.8%, respectively (P=0.001). Active treatment (P
Published: 2012

34. Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia

Author: Cho Bs, Junguee Lee, Min Ws, Shin Sh, Lee Se, Ki-Sung Eom, Kim Dw, Nak-Gyun Chung, Yoon Jh, Sung-Pil Lee, Seung-Ah Yahng, Yun Ju Kim, Park Cw, Chang-Ki Min, and Hyung-Ok Kim
Subjects: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Neoplasm, Residual, Adolescent, medicine.medical_treatment, Antineoplastic Agents, Hematopoietic stem cell transplantation, Real-Time Polymerase Chain Reaction, Philadelphia chromosome, Piperazines, Young Adult, hemic and lymphatic diseases, Internal medicine, Humans, Medicine, Philadelphia Chromosome, Chemotherapy, business.industry, Hematopoietic Stem Cell Transplantation, Imatinib, Hematology, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Prognosis, medicine.disease, Combined Modality Therapy, Minimal residual disease, Surgery, Transplantation, Leukemia, Pyrimidines, Imatinib mesylate, Benzamides, Imatinib Mesylate, Female, business, medicine.drug
Abstract: We conducted a systemic evaluation to describe the effect of minimal residual disease (MRD) kinetics on long-term allogeneic transplantation outcome by analyzing 95 adult transplants with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL) who received first-line two courses of imatinib-based chemotherapy (median follow-up 5 years). MRD monitoring was centrally evaluated by real-time quantitative PCR (4.5 log sensitivity). After the first course of imatinib-based chemotherapy, 33 patients (34.7%) achieved at least major molecular response. On the basis of MRD kinetics by the end of two courses of imatinib-based chemotherapy, we stratified entire patients into four subgroups: early-stable molecular responders (EMRs, n=33), late molecular responders (LMRs, n=35), intermediate molecular responders (IMRs, n=9) and poor molecular responders (PMRs, n=18). Multivariate analysis showed that the most powerful factor affecting long-term transplantation outcome was MRD kinetics. Compared with EMRs, IMRs or PMRs had significantly higher risk of treatment failure in terms of relapse and disease-free survival (DFS). LMRs had a tendency toward a lower DFS. Quantitative monitoring of MRD kinetics during the first-line imatinib-based chemotherapy course is useful in identifying subgroups of Ph-positive ALL transplants at a high risk of relapse.
Published: 2012

35. The Outcome of Unrelated Hematopoietic Stem Cell Transplants with Total Body Irradiation (800 cGy) and Cyclophosphamide (120 mg/kg) in Adult Patients with Acquired Severe Aplastic Anemia

Author: Seok-Goo Cho, Sung-Eun Lee, Chang-Ki Min, Yoo-Jin Kim, Hee-Je Kim, Ki Seong Eom, Seok Lee, Woo Sung Min, Jong Wook Lee, Byung Sik Cho, and Park Cw
Subjects: Adult, Male, medicine.medical_specialty, Transplantation Conditioning, Adolescent, Cyclophosphamide, Anemia, Graft vs Host Disease, Gastroenterology, Young Adult, immune system diseases, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Unrelated allogeneic stem cell transplantation, Aplastic anemia, Survival rate, Transplantation, business.industry, Incidence, Graft Survival, Hematopoietic Stem Cell Transplantation, Anemia, Aplastic, Hematology, Middle Aged, Total body irradiation, medicine.disease, Tacrolimus, Surgery, Survival Rate, TBI-based conditioning regimen, Treatment Outcome, surgical procedures, operative, medicine.anatomical_structure, Histocompatibility, Feasibility Studies, Female, Bone marrow, business, Immunosuppressive Agents, Whole-Body Irradiation, Follow-Up Studies, medicine.drug
Abstract: To verify the feasibility of 800 cGy of total body irradiation (TBI) with 120 mg/kg of cyclophosphamide (TBI-800/Cy-120) as a conditioning regimen for unrelated stem cell transplantation (u-SCT) in adult patients with severe aplastic anemia, we analyzed 50 consecutive patients who underwent u-SCT, including 26 patients from our previous pilot study. Seventeen patients received transplants from mismatched donors via high-resolution DNA typing (8 of 8). Thirty-eight patients received bone marrow and 12 peripheral blood stem cells (PBSCs). Graft-versus-host disease (GVHD) prophylaxis consisted of tacrolimus and short-course methotrexate. All patients achieved engraftment, and the median days of neutrophil and platelet recovery were 13 days and 20 days, respectively. The 5-year estimated overall survival was 88.0%. The cumulative incidences of acute grade II-IV GVHD (aGVHD) and chronic GVHD (cGVHD) were 46.0% and 50.3%, respectively. Only an HLA-mismatched donor was associated with the occurrence of aGVHD on multivariate analyses, whereas prior aGVHD and the use of PBSCs were associated with the occurrence of cGVHD on univariate analyses. In conclusion, the excellent outcomes of u-SCT with TBI-800/Cy-120 suggest that u-SCT may be applicable to patients with severe aplastic anemia even without prior treatment with immunosuppressive therapy, which will require testing in prospective trials in the future.
Published: 2011

36. Esophageal aspergillosis after bone marrow transplant

Author: Choi, JH, Yoo, JH, Chung, IJ, Kim, DW, Han, CW, Shin, WS, Min, WS, Park, CW, Kim, CC, and Kim, DJ
Published: 1997
Full Text: View/download PDF

37. HLA-matched sibling transplantation with BM and CD34+-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD

Author: Sung Hyun Lee, Park Cw, Seok-Goo Cho, Chang-Ki Min, Kim Yj, Chun-Choo Kim, Min Ws, Junguee Lee, Ki-Sung Eom, Hyung-Ok Kim, and Cho Bs
Subjects: Adult, Graft Rejection, Male, medicine.medical_specialty, Anemia, medicine.medical_treatment, Graft vs Host Disease, Antigens, CD34, Hematopoietic stem cell transplantation, Severity of Illness Index, Gastroenterology, Young Adult, Risk Factors, Internal medicine, medicine, Humans, Aplastic anemia, Survival analysis, Bone Marrow Transplantation, Retrospective Studies, Peripheral Blood Stem Cell Transplantation, Transplantation, business.industry, Incidence, Siblings, Bone marrow failure, Anemia, Aplastic, Hematology, Middle Aged, medicine.disease, Survival Analysis, Tissue Donors, Fludarabine, surgical procedures, operative, Graft-versus-host disease, Histocompatibility, Immunology, Female, business, medicine.drug
Abstract: The transplantation of a large number of stem cells can overcome graft rejection but with the increased risk of GVHD. In this study, we analyzed the outcome of 32 adult patients with acquired severe aplastic anemia (SAA) who were at a high risk for graft rejection, including multiple transfusions (median 147 units, range 20-680) and long disease duration (median 67 months, range 3-347), and who had received both BM and CD34(+)-purified PBSCs from an HLA-matched sibling donor to reduce graft rejection. T cells in PBSCs were depleted using a magnetic-activated cell sorting method (CliniMACS system). Conditioning regimens consisted largely of CY and antithymocyte globulin (ATG) with fludarabine (FLU) or procarbazine (PCB). With a median follow-up of 89 months, the 8-year probability of survival was 87.5%. Neutrophils and plts promptly recovered, and none of the patients developed graft failure. The cumulative incidences of acute and chronic GVHD were 9.4 and 18.0%, respectively. Sustained engraftment and excellent survival without an apparent increase in the rate of GVHD in high-risk patients using the current approach showed that high-dose SCT with both BM and CD34(+)-purified PBSCs may yield better outcomes in heavily transfused and/or allo-immunized patients with SAA.
Published: 2010

38. The effects of warming methods on temperature, cardiac function and cytokines in plateletpheresis donors

Author: N. C. Kim, Park Cw, and Hyung-Ok Kim
Subjects: Adult, Cardiac function curve, Hot Temperature, Plateletpheresis, Hemodynamics, Blood Donors, Hypothermia, Body Temperature, Young Adult, Heart rate, Humans, Medicine, Platelet, business.industry, Heart, Hematology, General Medicine, Apheresis, Blood pressure, Anesthesia, Cytokines, medicine.symptom, business
Abstract: Background and Objectives Plateletpheresis is the most frequent type of apheresis, with demand for these products continuously increasing. Hypothermia is a common side-effect of apheresis, which may have an effect on the donor's body functions. The aim of this study was to examine the effects of warming methods on plateletpheresis donors’ temperature, cardiac function and cytokines. Materials and Methods Fifty plateletpheresis donors were randomly assigned to a control group (n = 25) or a warming group (n = 25), with air and blood warmers during plateletpheresis. The effects of the treatment were examined by comparing body temperature, heart rate, blood pressure, Holter EKG pattern, serum interleukin-1β (IL-1β), interleukin-2 (IL-2), tumour necrosis factor-α (TNF-α) concentration, the white blood count, the white blood fraction, and the platelet count at a point in time between the two groups. Results In the control group, the tympanic temperature decreased more during apheresis compared to the warming group (P = 0·014). The decrease of diastolic blood pressure was significantly greater in the control group compared to the warming group (P = 0·010). As for cardiac function, the frequency of abnormal beats was generally higher in the control group, but the difference was not significant. IL-2 and TNF-α decreased significantly after plateletpheresis in the control group only, while there was no change in the warming group. Conclusion The decrease of temperature during plateletpheresis resulted in changes in haemodynamics and cytokines. The warming methods used in this study can prevent the decrease of temperature in donors, and may be helpful in maintaining the haemodynamic and cytokine balance.
Published: 2008

39. What factors determine the need for lumbar puncture in patients with fever and headache?

Author: Kim, KJ, primary, Cho, JH, additional, Moon, JB, additional, Shin, MC, additional, Ohk, TG, additional, Lee, HY, additional, and Park, CW, additional
Published: 2017
Full Text: View/download PDF

40. Measurements of the Upsilon(10860) and Upsilon(11020) resonances via sigma(e(+)e(-) -> Upsilon(nS)pi(+)pi(-))

Author: Santel, D, Kinoshita, K, Chang, P, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Aushev, T, Ayad, R, Bakich, AM, Bansal, V, Bhuyan, B, Bobrov, A, Bondar, A, Bonvicini, G, Bracko, M, Browder, TE, Cervenkov, D, Chekelian, V, Cheon, BG, Chilikin, K, Cho, K, Chobanova, V, Choi, S-K, Choi, Y, Cinabro, D, Dalseno, J, Danilov, M, Dingfelder, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Gaur, V, Gabyshev, N, Garmash, A, Getzkow, D, Gillard, R, Goh, M, Haba, J, Hara, T, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Hyun, HJ, Iijima, T, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, Y, Jaegle, I, Joffe, D, Julius, T, Kang, KH, Kato, E, Kawasaki, T, Kiesling, C, Kim, DY, Kim, HJ, Kim, JB, Kim, JH, Kim, MJ, Kim, SH, Kim, YJ, Ko, BR, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kuzmin, A, Lange, JS, Lee, IS, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyabayashi, K, Miyata, H, Mizuk, R, Mohanty, GB, Moll, A, Mori, T, Mussa, R, Nakano, E, Nakao, M, Nanut, T, Natkaniec, Z, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Olsen, SL, Oswald, C, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Petric, M, Piilonen, LE, Ribezl, E, Ritter, M, Rostomyan, A, Ryu, S, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Schwartz, AJ, Senyo, K, Sevior, ME, Shebalin, V, Shibata, T-A, Shiu, J-G, Shwartz, B, Sibidanov, A, Simon, F, Sohn, Y-S, Solovieva, E, Staric, M, Steder, M, Tamponi, U, Tatishvili, G, Teramoto, Y, Trabelsi, K, Uchida, M, Uehara, S, Uglov, T, Unno, Y, Uno, S, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Wagner, MN, Wang, P, Wang, XL, Watanabe, M, Watanabe, Y, Won, E, Yamaoka, J, Yang, Y-P, Yashchenko, S, Yook, Y, Yusa, Y, Zhang, ZP, Zhilich, V, Zhulanov, V, Zupanc, A, Santel, D, Kinoshita, K, Chang, P, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Aushev, T, Ayad, R, Bakich, AM, Bansal, V, Bhuyan, B, Bobrov, A, Bondar, A, Bonvicini, G, Bracko, M, Browder, TE, Cervenkov, D, Chekelian, V, Cheon, BG, Chilikin, K, Cho, K, Chobanova, V, Choi, S-K, Choi, Y, Cinabro, D, Dalseno, J, Danilov, M, Dingfelder, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Gaur, V, Gabyshev, N, Garmash, A, Getzkow, D, Gillard, R, Goh, M, Haba, J, Hara, T, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Hyun, HJ, Iijima, T, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, Y, Jaegle, I, Joffe, D, Julius, T, Kang, KH, Kato, E, Kawasaki, T, Kiesling, C, Kim, DY, Kim, HJ, Kim, JB, Kim, JH, Kim, MJ, Kim, SH, Kim, YJ, Ko, BR, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kuzmin, A, Lange, JS, Lee, IS, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyabayashi, K, Miyata, H, Mizuk, R, Mohanty, GB, Moll, A, Mori, T, Mussa, R, Nakano, E, Nakao, M, Nanut, T, Natkaniec, Z, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Olsen, SL, Oswald, C, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Petric, M, Piilonen, LE, Ribezl, E, Ritter, M, Rostomyan, A, Ryu, S, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Schwartz, AJ, Senyo, K, Sevior, ME, Shebalin, V, Shibata, T-A, Shiu, J-G, Shwartz, B, Sibidanov, A, Simon, F, Sohn, Y-S, Solovieva, E, Staric, M, Steder, M, Tamponi, U, Tatishvili, G, Teramoto, Y, Trabelsi, K, Uchida, M, Uehara, S, Uglov, T, Unno, Y, Uno, S, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Wagner, MN, Wang, P, Wang, XL, Watanabe, M, Watanabe, Y, Won, E, Yamaoka, J, Yang, Y-P, Yashchenko, S, Yook, Y, Yusa, Y, Zhang, ZP, Zhilich, V, Zhulanov, V, and Zupanc, A
Published: 2016

41. Autologous stem cell transplantation using modified TAM or combination of triple-alkylating agents conditioning regimens as one of the post-remission treatments in patients with adult acute myeloid leukemia in first complete remission

Author: Hyung-Ok Kim, Ki-Sung Eom, Yune-Jung Park, Silvia Park, Chun-Choo Kim, Dong-Kee Kim, Junguee Lee, Min Ws, and Park Cw
Subjects: Adult, Male, Melphalan, Alkylating Agents, medicine.medical_specialty, Time Factors, Transplantation Conditioning, Adolescent, medicine.medical_treatment, Transplantation, Autologous, Gastroenterology, Disease-Free Survival, Immunophenotyping, Autologous stem-cell transplantation, Internal medicine, medicine, Humans, Autologous transplantation, Survival rate, Transplantation, Chemotherapy, business.industry, Adult Acute Myeloid Leukemia, Hematology, Middle Aged, Total body irradiation, Surgery, Leukemia, Myeloid, Acute Disease, Cytarabine, Drug Therapy, Combination, Female, business, Stem Cell Transplantation, medicine.drug
Abstract: A total of 174 newly diagnosed adult acute myeloid leukaemia (AML) patients were treated in first complete remission (CR1) using modified TAM or a combination of triple-alkylating agents followed by autologous transplantation (AT). Cytogenetic risk groups were classified and most patients received mobilized peripheral blood stem/progenitor cells (PBSCs). The infused cell dose consisted of a median of 4.1+/-2 (range, 1.2-17.1)x 10(6)/kg CD34+ cells. With a median follow-up of 51 months (range, 5-131 months) after CR1, the estimated 5-year disease-free survival (DFS) rate was 68 (95% confidence interval (CI), 63-73%) and the event-free survival rate at 5 years was 59 (95% CI, 54-64%). AML patients other than M3 subtype, the long-term DFS rate was 76, 33% for favourable and unfavourable risk groups, respectively. In all, 40 patients had relapses (40/174, 23%) at the median 15 months after CR1 (range, 8-66 months). Overall, seven patients (4%) died in connection with AT. The infused CD34+ cell dose (P=0.0389) was associated with survival by multivariate analysis. In conclusion, two novel conditioning regimens in AT are feasible for adults with variable risk AML followed for over a 10-year period.
Published: 2004

42. Inclusive cross sections for pairs of identified light charged hadrons and for single protons in e+e- at √s=10.58 GeV

Author: Seidl, R, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Asner, DM, Aushev, T, Ayad, R, Babu, V, Badhrees, I, Bakich, AM, Barberio, E, Bhardwaj, V, Bhuyan, B, Biswal, J, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Cho, K, Chobanova, V, Choi, Y, Cinabro, D, Dalseno, J, Dash, N, Dingfelder, J, Dolezal, Z, Drasal, Z, Dutta, D, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Fulsom, BG, Gaur, V, Gabyshev, N, Garmash, A, Gillard, R, Giordano, F, Goh, YM, Goldenzweig, P, Golob, B, Haba, J, Hara, T, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Hsu, C-L, Iijima, T, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, Y, Jacobs, WW, Jaegle, I, Joffe, D, Joo, KK, Kang, KH, Kato, E, Katrenko, P, Kawasaki, T, Kim, DY, Kim, HJ, Kim, JB, Kim, JH, Kim, KT, Kim, MJ, Kim, SH, Kim, YJ, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kuzmin, A, Kwon, Y-J, Lange, JS, Lee, DH, Li, L, Gioi, LL, Libby, J, Liu, Y, Liventsev, D, Lukin, P, Masuda, M, Matvienko, D, Miyabayashi, K, Miyake, H, Miyata, H, Mizuk, R, Mohanty, S, Moll, A, Moon, HK, Mori, T, Mussa, R, Nakano, E, Nakao, M, Nanut, T, Natkaniec, Z, Nayak, M, Niiyama, M, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Oswald, C, Pakhlov, P, Pakhlova, G, Pal, B, Park, CW, Park, H, Pedlar, TK, Pestotnik, R, Petric, M, Piilonen, LE, Ribezl, E, Ritter, M, Rostomyan, A, Ryu, S, Sahoo, H, Sakai, K, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Seino, Y, Senyo, K, Seon, O, Sevior, ME, Shebalin, V, Shibata, T-A, Shiu, J-G, Simon, F, Sohn, Y-S, Sokolov, A, Solovieva, E, Staric, M, Sumihama, M, Sumisawa, K, Sumiyoshi, T, Tamponi, U, Teramoto, Y, Trusov, V, Uchida, M, Uglov, T, Unno, Y, Uno, S, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vorobyev, V, Vossen, A, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Watanabe, M, Watanabe, Y, Williams, KM, Won, E, Yamaoka, J, Yashchenko, S, Yelton, J, Yusa, Y, Zhang, ZP, Zhilich, V, Zhulanov, V, Seidl, R, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Asner, DM, Aushev, T, Ayad, R, Babu, V, Badhrees, I, Bakich, AM, Barberio, E, Bhardwaj, V, Bhuyan, B, Biswal, J, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Cho, K, Chobanova, V, Choi, Y, Cinabro, D, Dalseno, J, Dash, N, Dingfelder, J, Dolezal, Z, Drasal, Z, Dutta, D, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Fulsom, BG, Gaur, V, Gabyshev, N, Garmash, A, Gillard, R, Giordano, F, Goh, YM, Goldenzweig, P, Golob, B, Haba, J, Hara, T, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Hsu, C-L, Iijima, T, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, Y, Jacobs, WW, Jaegle, I, Joffe, D, Joo, KK, Kang, KH, Kato, E, Katrenko, P, Kawasaki, T, Kim, DY, Kim, HJ, Kim, JB, Kim, JH, Kim, KT, Kim, MJ, Kim, SH, Kim, YJ, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kuzmin, A, Kwon, Y-J, Lange, JS, Lee, DH, Li, L, Gioi, LL, Libby, J, Liu, Y, Liventsev, D, Lukin, P, Masuda, M, Matvienko, D, Miyabayashi, K, Miyake, H, Miyata, H, Mizuk, R, Mohanty, S, Moll, A, Moon, HK, Mori, T, Mussa, R, Nakano, E, Nakao, M, Nanut, T, Natkaniec, Z, Nayak, M, Niiyama, M, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Oswald, C, Pakhlov, P, Pakhlova, G, Pal, B, Park, CW, Park, H, Pedlar, TK, Pestotnik, R, Petric, M, Piilonen, LE, Ribezl, E, Ritter, M, Rostomyan, A, Ryu, S, Sahoo, H, Sakai, K, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Seino, Y, Senyo, K, Seon, O, Sevior, ME, Shebalin, V, Shibata, T-A, Shiu, J-G, Simon, F, Sohn, Y-S, Sokolov, A, Solovieva, E, Staric, M, Sumihama, M, Sumisawa, K, Sumiyoshi, T, Tamponi, U, Teramoto, Y, Trusov, V, Uchida, M, Uglov, T, Unno, Y, Uno, S, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vorobyev, V, Vossen, A, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Watanabe, M, Watanabe, Y, Williams, KM, Won, E, Yamaoka, J, Yashchenko, S, Yelton, J, Yusa, Y, Zhang, ZP, Zhilich, V, and Zhulanov, V
Published: 2015

43. Measurement of the branching ratio of (B)over-bar -> D-(())tau(-)(nu)over-bar(tau) relative to (B)over-bar -> D()l(-)(nu)over-bar(l) decays with hadronic tagging at Belle

Author: Huschle, M, Kuhr, T, Heck, M, Goldenzweig, P, Abdesselam, A, Adachi, I, Adamczyk, K, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Aushev, T, Ayad, R, Aziz, T, Badhrees, I, Bakich, AM, Bansal, V, Barberio, E, Bhardwaj, V, Bhuyan, B, Biswal, J, Bobrov, A, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chang, P, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Chistov, R, Cho, K, Chobanova, V, Choi, Y, Cinabro, D, Dalseno, J, Danilov, M, Dolezal, Z, Drasal, Z, Dutta, D, Eidelman, S, Epifanov, D, Farhat, H, Fast, JE, Ferber, T, Frey, A, Fulsom, BG, Gaur, V, Gabyshev, N, Garmash, A, Gillard, R, Glattauer, R, Goh, YM, Golob, B, Grygier, J, Hamer, P, Hara, K, Hara, T, Hasenbusch, J, Hayasaka, K, Hayashii, H, He, XH, Heider, M, Heller, A, Horiguchi, T, Hou, W-S, Hsu, C-L, Iijima, T, Inami, K, Inguglia, G, Ishikawa, A, Itoh, R, Iwasaki, Y, Jaegle, I, Joffe, D, Joo, KK, Julius, T, Kang, KH, Kato, E, Katrenko, P, Kawasaki, T, Keck, T, Kiesling, C, Kim, DY, Kim, HJ, Kim, JB, Kim, JH, Kim, KT, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kobayashi, N, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kumita, T, Kuzmin, A, Kwon, Y-J, Lee, IS, Li, C, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Masuda, M, Matvienko, D, Miyabayashi, K, Miyake, H, Miyata, H, Mizuk, R, Mohanty, GB, Mohanty, S, Moll, A, Moon, HK, Mussa, R, Nakamura, KR, Nakano, E, Nakao, M, Nanut, T, Nayak, M, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Oswald, C, Pakhlova, G, Pal, B, Park, CW, Park, H, Pedlar, TK, Pesantez, L, Pestotnik, R, Petric, M, Piilonen, LE, Pulvermacher, C, Ribezl, E, Ritter, M, Rostomyan, A, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Sato, Y, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Schwartz, AJ, Semmler, D, Senyo, K, Seon, O, Sevior, ME, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Simon, F, Sohn, Y-S, Sokolov, A, Solovieva, E, Stanic, S, Staric, M, Steder, M, Stypula, J, Sumihama, M, Sumiyoshi, T, Tamponi, U, Teramoto, Y, Trabelsi, K, Trusov, V, Uchida, M, Uglov, T, Uno, S, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Vorobyev, V, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Wang, XL, Watanabe, M, Watanabe, Y, Won, E, Yamamoto, H, Yamaoka, J, Yashchenko, S, Ye, H, Yook, Y, Yuan, CZ, Yusa, Y, Zhang, ZP, Zhilich, V, Zhulanov, V, Zupanc, A, Huschle, M, Kuhr, T, Heck, M, Goldenzweig, P, Abdesselam, A, Adachi, I, Adamczyk, K, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Aushev, T, Ayad, R, Aziz, T, Badhrees, I, Bakich, AM, Bansal, V, Barberio, E, Bhardwaj, V, Bhuyan, B, Biswal, J, Bobrov, A, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chang, P, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Chistov, R, Cho, K, Chobanova, V, Choi, Y, Cinabro, D, Dalseno, J, Danilov, M, Dolezal, Z, Drasal, Z, Dutta, D, Eidelman, S, Epifanov, D, Farhat, H, Fast, JE, Ferber, T, Frey, A, Fulsom, BG, Gaur, V, Gabyshev, N, Garmash, A, Gillard, R, Glattauer, R, Goh, YM, Golob, B, Grygier, J, Hamer, P, Hara, K, Hara, T, Hasenbusch, J, Hayasaka, K, Hayashii, H, He, XH, Heider, M, Heller, A, Horiguchi, T, Hou, W-S, Hsu, C-L, Iijima, T, Inami, K, Inguglia, G, Ishikawa, A, Itoh, R, Iwasaki, Y, Jaegle, I, Joffe, D, Joo, KK, Julius, T, Kang, KH, Kato, E, Katrenko, P, Kawasaki, T, Keck, T, Kiesling, C, Kim, DY, Kim, HJ, Kim, JB, Kim, JH, Kim, KT, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kobayashi, N, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kumita, T, Kuzmin, A, Kwon, Y-J, Lee, IS, Li, C, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Masuda, M, Matvienko, D, Miyabayashi, K, Miyake, H, Miyata, H, Mizuk, R, Mohanty, GB, Mohanty, S, Moll, A, Moon, HK, Mussa, R, Nakamura, KR, Nakano, E, Nakao, M, Nanut, T, Nayak, M, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Oswald, C, Pakhlova, G, Pal, B, Park, CW, Park, H, Pedlar, TK, Pesantez, L, Pestotnik, R, Petric, M, Piilonen, LE, Pulvermacher, C, Ribezl, E, Ritter, M, Rostomyan, A, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Sato, Y, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Schwartz, AJ, Semmler, D, Senyo, K, Seon, O, Sevior, ME, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Simon, F, Sohn, Y-S, Sokolov, A, Solovieva, E, Stanic, S, Staric, M, Steder, M, Stypula, J, Sumihama, M, Sumiyoshi, T, Tamponi, U, Teramoto, Y, Trabelsi, K, Trusov, V, Uchida, M, Uglov, T, Uno, S, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Vorobyev, V, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Wang, XL, Watanabe, M, Watanabe, Y, Won, E, Yamamoto, H, Yamaoka, J, Yashchenko, S, Ye, H, Yook, Y, Yuan, CZ, Yusa, Y, Zhang, ZP, Zhilich, V, Zhulanov, V, and Zupanc, A
Published: 2015

44. Semi-inclusive studies of semileptonic Bs decays at Belle

Author: Oswald, C, Urquijo, P, Dingfelder, J, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Asner, DM, Aushev, T, Ayad, R, Babu, V, Badhrees, I, Bakich, AM, Bhardwaj, V, Bobrov, A, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chang, M-C, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Cho, K, Chobanova, V, Choi, Y, Cinabro, D, Dalseno, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Dutta, D, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Frost, O, Fulsom, BG, Gaur, V, Gabyshev, N, Ganguly, S, Garmash, A, Getzkow, D, Gillard, R, Glattauer, R, Goh, YM, Goldenzweig, P, Golob, B, Grzymkowska, O, Hara, T, Hasenbusch, J, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Huschle, M, Hyun, HJ, Iijima, T, Ishikawa, A, Itoh, R, Iwasaki, Y, Jaegle, I, Julius, T, Kang, KH, Kapusta, P, Kato, E, Kawasaki, T, Kiesling, C, Kim, DY, Kim, JB, Kim, JH, Kim, KT, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kuhr, T, Kumita, T, Kwon, Y-J, Lange, JS, Lee, DH, Lee, IS, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyata, H, Mizuk, R, Mohanty, GB, Moll, A, Moon, HK, Nakano, E, Nakao, M, Nakazawa, H, Nanut, T, Natkaniec, Z, Nayak, M, Nishida, S, Nozaki, T, Okuno, S, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Pesantez, L, Pestotnik, R, Petric, M, Piilonen, LE, Pulvermacher, C, Ribezl, E, Ritter, M, Rostomyan, A, Rozanska, M, Ryu, S, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Sato, Y, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Semmler, D, Senyo, K, Seon, O, Sevior, ME, Shapkin, M, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Sibidanov, A, Simon, F, Sohn, Y-S, Solovieva, E, Stanic, S, Staric, M, Stypula, J, Sumihama, M, Sumiyoshi, T, Tamponi, U, Teramoto, Y, Trabelsi, K, Uchida, M, Unno, Y, Uno, S, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Vorobyev, V, Vossen, A, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Wang, XL, Watanabe, Y, Williams, KM, Won, E, Yamamoto, H, Yashchenko, S, Yook, Y, Zhang, ZP, Zhilich, V, Zhulanov, V, Zupanc, A, Oswald, C, Urquijo, P, Dingfelder, J, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Asner, DM, Aushev, T, Ayad, R, Babu, V, Badhrees, I, Bakich, AM, Bhardwaj, V, Bobrov, A, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chang, M-C, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Cho, K, Chobanova, V, Choi, Y, Cinabro, D, Dalseno, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Dutta, D, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Frost, O, Fulsom, BG, Gaur, V, Gabyshev, N, Ganguly, S, Garmash, A, Getzkow, D, Gillard, R, Glattauer, R, Goh, YM, Goldenzweig, P, Golob, B, Grzymkowska, O, Hara, T, Hasenbusch, J, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Huschle, M, Hyun, HJ, Iijima, T, Ishikawa, A, Itoh, R, Iwasaki, Y, Jaegle, I, Julius, T, Kang, KH, Kapusta, P, Kato, E, Kawasaki, T, Kiesling, C, Kim, DY, Kim, JB, Kim, JH, Kim, KT, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kuhr, T, Kumita, T, Kwon, Y-J, Lange, JS, Lee, DH, Lee, IS, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyata, H, Mizuk, R, Mohanty, GB, Moll, A, Moon, HK, Nakano, E, Nakao, M, Nakazawa, H, Nanut, T, Natkaniec, Z, Nayak, M, Nishida, S, Nozaki, T, Okuno, S, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Pesantez, L, Pestotnik, R, Petric, M, Piilonen, LE, Pulvermacher, C, Ribezl, E, Ritter, M, Rostomyan, A, Rozanska, M, Ryu, S, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Sato, Y, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Semmler, D, Senyo, K, Seon, O, Sevior, ME, Shapkin, M, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Sibidanov, A, Simon, F, Sohn, Y-S, Solovieva, E, Stanic, S, Staric, M, Stypula, J, Sumihama, M, Sumiyoshi, T, Tamponi, U, Teramoto, Y, Trabelsi, K, Uchida, M, Unno, Y, Uno, S, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Vorobyev, V, Vossen, A, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Wang, XL, Watanabe, Y, Williams, KM, Won, E, Yamamoto, H, Yashchenko, S, Yook, Y, Zhang, ZP, Zhilich, V, Zhulanov, V, and Zupanc, A
Published: 2015

45. Search for B decays to final states with the eta(c) meson

Author: Vinokurova, A, Kuzmin, A, Eidelman, S, Abdesselam, A, Adachi, I, Aihara, H, Arinstein, K, Asner, DM, Aushev, T, Ayad, R, Bakich, AM, Bansal, V, Bhardwaj, V, Bhuyan, B, Bobrov, A, Bondar, A, Bozek, A, Bracko, M, Browder, TE, Chekelian, V, Cheon, BG, Chilikin, K, Chistov, R, Cho, K, Choi, S-K, Choi, Y, Cinabro, D, Dingfelder, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Dutta, D, Epifanov, D, Farhat, H, Fast, JE, Ferber, T, Gaur, V, Gabyshev, N, Garmash, A, Gillard, R, Goh, YM, Golob, B, Haba, J, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, Y, Joffe, D, Julius, T, Kang, KH, Kato, E, Kiesling, C, Kim, DY, Kim, HJ, Kim, JH, Kim, KT, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kuhr, T, Kumita, T, Kwon, Y-J, Lange, JS, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyabayashi, K, Miyake, H, Miyata, H, Mohanty, GB, Moll, A, Mori, T, Mussa, R, Nakano, E, Nakao, M, Natkaniec, Z, Ng, C, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Olsen, SL, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Pestotnik, R, Petric, M, Piilonen, LE, Ribezl, E, Ritter, M, Rostomyan, A, Sakai, Y, Sandilya, S, Santel, D, Santelj, L, Sanuki, T, Sato, Y, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Semmler, D, Senyo, K, Seon, O, Sevior, ME, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Shwartz, B, Sibidanov, A, Simon, F, Sohn, Y-S, Sokolov, A, Solovieva, E, Stanic, S, Staric, M, Steder, M, Sumihama, M, Sumiyoshi, T, Tamponi, U, Tatishvili, G, Teramoto, Y, Uchida, M, Uglov, T, Unno, Y, Uno, S, Van Hulse, C, Vanhoefer, P, Varner, G, Vorobyev, V, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Watanabe, Y, Williams, KM, Won, E, Yamaoka, J, Yashchenko, S, Yook, Y, Zhang, ZP, Zhulanov, V, Zupanc, A, Vinokurova, A, Kuzmin, A, Eidelman, S, Abdesselam, A, Adachi, I, Aihara, H, Arinstein, K, Asner, DM, Aushev, T, Ayad, R, Bakich, AM, Bansal, V, Bhardwaj, V, Bhuyan, B, Bobrov, A, Bondar, A, Bozek, A, Bracko, M, Browder, TE, Chekelian, V, Cheon, BG, Chilikin, K, Chistov, R, Cho, K, Choi, S-K, Choi, Y, Cinabro, D, Dingfelder, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Dutta, D, Epifanov, D, Farhat, H, Fast, JE, Ferber, T, Gaur, V, Gabyshev, N, Garmash, A, Gillard, R, Goh, YM, Golob, B, Haba, J, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, Y, Joffe, D, Julius, T, Kang, KH, Kato, E, Kiesling, C, Kim, DY, Kim, HJ, Kim, JH, Kim, KT, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kuhr, T, Kumita, T, Kwon, Y-J, Lange, JS, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyabayashi, K, Miyake, H, Miyata, H, Mohanty, GB, Moll, A, Mori, T, Mussa, R, Nakano, E, Nakao, M, Natkaniec, Z, Ng, C, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Olsen, SL, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Pestotnik, R, Petric, M, Piilonen, LE, Ribezl, E, Ritter, M, Rostomyan, A, Sakai, Y, Sandilya, S, Santel, D, Santelj, L, Sanuki, T, Sato, Y, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Semmler, D, Senyo, K, Seon, O, Sevior, ME, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Shwartz, B, Sibidanov, A, Simon, F, Sohn, Y-S, Sokolov, A, Solovieva, E, Stanic, S, Staric, M, Steder, M, Sumihama, M, Sumiyoshi, T, Tamponi, U, Tatishvili, G, Teramoto, Y, Uchida, M, Uglov, T, Unno, Y, Uno, S, Van Hulse, C, Vanhoefer, P, Varner, G, Vorobyev, V, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Watanabe, Y, Williams, KM, Won, E, Yamaoka, J, Yashchenko, S, Yook, Y, Zhang, ZP, Zhulanov, V, and Zupanc, A
Published: 2015

46. Evidence for the decay B-0 -> eta pi(0)

Author: Pal, B, Schwartz, AJ, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Aulchenko, V, Aushev, T, Ayad, R, Babu, V, Badhrees, I, Bakich, AM, Bobrov, A, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chang, M-C, Chekelian, V, Chen, A, Cheon, BG, Cho, K, Chobanova, V, Choi, Y, Cinabro, D, Dalseno, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Dutta, D, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Frost, O, Fulsom, BG, Gaur, V, Gabyshev, N, Ganguly, S, Garmash, A, Getzkow, D, Gillard, R, Glattauer, R, Goh, YM, Golob, B, Grzymkowska, O, Hara, T, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Huschle, M, Hyun, HJ, Iijima, T, Ishikawa, A, Itoh, R, Iwasaki, Y, Jaegle, I, Julius, T, Kang, KH, Kato, E, Kiesling, C, Kim, DY, Kim, JB, Kim, JH, Kim, KT, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kuhr, T, Kumita, T, Kuzmin, A, Kwon, Y-J, Lange, JS, Lee, DH, Lee, IS, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyata, H, Mohanty, GB, Moll, A, Moon, HK, Nakamura, KR, Nakano, E, Nakao, M, Nanut, T, Natkaniec, Z, Nayak, M, Nishida, S, Ogawa, S, Okuno, S, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Pesantez, L, Petric, M, Piilonen, LE, Pulvermacher, C, Ribezl, E, Ritter, M, Rostomyan, A, Ryu, S, Sakai, Y, Sandilya, S, Santel, D, Santelj, L, Sanuki, T, Sato, Y, Schneider, O, Schnell, G, Schwanda, C, Senyo, K, Seon, O, Sevior, ME, Shapkin, M, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Sibidanov, A, Simon, F, Sohn, Y-S, Solovieva, E, Stanic, S, Staric, M, Sumihama, M, Sumisawa, K, Sumiyoshi, T, Tamponi, U, Teramoto, Y, Thorne, F, Uchida, M, Uehara, S, Unno, Y, Uno, S, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Vorobyev, V, Vossen, A, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Wang, XL, Watanabe, Y, Won, E, Yamamoto, H, Yamaoka, J, Yashchenko, S, Zhang, ZP, Zhilich, V, Zhulanov, V, Zupanc, A, Pal, B, Schwartz, AJ, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Aulchenko, V, Aushev, T, Ayad, R, Babu, V, Badhrees, I, Bakich, AM, Bobrov, A, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chang, M-C, Chekelian, V, Chen, A, Cheon, BG, Cho, K, Chobanova, V, Choi, Y, Cinabro, D, Dalseno, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Dutta, D, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Frost, O, Fulsom, BG, Gaur, V, Gabyshev, N, Ganguly, S, Garmash, A, Getzkow, D, Gillard, R, Glattauer, R, Goh, YM, Golob, B, Grzymkowska, O, Hara, T, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Huschle, M, Hyun, HJ, Iijima, T, Ishikawa, A, Itoh, R, Iwasaki, Y, Jaegle, I, Julius, T, Kang, KH, Kato, E, Kiesling, C, Kim, DY, Kim, JB, Kim, JH, Kim, KT, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kuhr, T, Kumita, T, Kuzmin, A, Kwon, Y-J, Lange, JS, Lee, DH, Lee, IS, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyata, H, Mohanty, GB, Moll, A, Moon, HK, Nakamura, KR, Nakano, E, Nakao, M, Nanut, T, Natkaniec, Z, Nayak, M, Nishida, S, Ogawa, S, Okuno, S, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Pesantez, L, Petric, M, Piilonen, LE, Pulvermacher, C, Ribezl, E, Ritter, M, Rostomyan, A, Ryu, S, Sakai, Y, Sandilya, S, Santel, D, Santelj, L, Sanuki, T, Sato, Y, Schneider, O, Schnell, G, Schwanda, C, Senyo, K, Seon, O, Sevior, ME, Shapkin, M, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Sibidanov, A, Simon, F, Sohn, Y-S, Solovieva, E, Stanic, S, Staric, M, Sumihama, M, Sumisawa, K, Sumiyoshi, T, Tamponi, U, Teramoto, Y, Thorne, F, Uchida, M, Uehara, S, Unno, Y, Uno, S, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Vorobyev, V, Vossen, A, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Wang, XL, Watanabe, Y, Won, E, Yamamoto, H, Yamaoka, J, Yashchenko, S, Zhang, ZP, Zhilich, V, Zhulanov, V, and Zupanc, A
Published: 2015

47. Study of D** production and light hadronic states in the (B)over-bar(0) -> D*(+)omega pi(-) decay

Author: Matvienko, D, Kuzmin, A, Eidelman, S, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Aulchenko, V, Aushev, T, Ayad, R, Babu, V, Badhrees, I, Bahinipati, S, Bakich, AM, Bansal, V, Bhardwaj, V, Bhuyan, B, Biswal, J, Bobrov, A, Bondar, A, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chen, A, Cheon, BG, Chilikin, K, Chistov, R, Cho, K, Chobanova, V, Choi, S-K, Choi, Y, Cinabro, D, Dalseno, J, Dingfelder, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Dutta, D, Epifanov, D, Farhat, H, Fast, JE, Ferber, T, Fulsom, BG, Gaur, V, Gabyshev, N, Garmash, A, Getzkow, D, Gillard, R, Goh, YM, Goldenzweig, P, Golob, B, Hara, T, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Iijima, T, Inguglia, G, Ishikawa, A, Itoh, R, Iwasaki, Y, Jaegle, I, Joffe, D, Joo, KK, Julius, T, Kawasaki, T, Kim, DY, Kim, JB, Kim, JH, Kim, KT, Kim, MJ, Kim, SH, Kim, YJ, Ko, BR, Kodys, P, Korpar, S, Krokovny, P, Kumar, R, Lange, JS, Lee, DH, Li Gioi, L, Libby, J, Liventsev, D, Miyabayashi, K, Miyata, H, Mizuk, R, Mohanty, GB, Moll, A, Mussa, R, Nakano, E, Nakao, M, Nanut, T, Nayak, M, Nisar, NK, Nishida, S, Ogawa, S, Pakhlova, G, Pal, B, Park, CW, Park, H, Pedlar, TK, Pesantez, L, Pestotnik, R, Petric, M, Piilonen, LE, Pulvermacher, C, Ribezl, E, Ritter, M, Rostomyan, A, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Schneider, O, Schnell, G, Schwanda, C, Senyo, K, Seon, O, Sevior, ME, Shapkin, M, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Shwartz, B, Sibidanov, A, Simon, F, Sohn, Y-S, Sokolov, A, Staric, M, Steder, M, Sumihama, M, Sumisawa, K, Tamponi, U, Tanida, K, Teramoto, Y, Uchida, M, Uehara, S, Unno, Y, Uno, S, Urquijo, P, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Vorobyev, V, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Watanabe, Y, Williams, KM, Won, E, Yamamoto, H, Yashchenko, S, Yook, Y, Zhang, ZP, Zhilich, V, Zhulanov, V, Zupanc, A, Matvienko, D, Kuzmin, A, Eidelman, S, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Aulchenko, V, Aushev, T, Ayad, R, Babu, V, Badhrees, I, Bahinipati, S, Bakich, AM, Bansal, V, Bhardwaj, V, Bhuyan, B, Biswal, J, Bobrov, A, Bondar, A, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chen, A, Cheon, BG, Chilikin, K, Chistov, R, Cho, K, Chobanova, V, Choi, S-K, Choi, Y, Cinabro, D, Dalseno, J, Dingfelder, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Dutta, D, Epifanov, D, Farhat, H, Fast, JE, Ferber, T, Fulsom, BG, Gaur, V, Gabyshev, N, Garmash, A, Getzkow, D, Gillard, R, Goh, YM, Goldenzweig, P, Golob, B, Hara, T, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Iijima, T, Inguglia, G, Ishikawa, A, Itoh, R, Iwasaki, Y, Jaegle, I, Joffe, D, Joo, KK, Julius, T, Kawasaki, T, Kim, DY, Kim, JB, Kim, JH, Kim, KT, Kim, MJ, Kim, SH, Kim, YJ, Ko, BR, Kodys, P, Korpar, S, Krokovny, P, Kumar, R, Lange, JS, Lee, DH, Li Gioi, L, Libby, J, Liventsev, D, Miyabayashi, K, Miyata, H, Mizuk, R, Mohanty, GB, Moll, A, Mussa, R, Nakano, E, Nakao, M, Nanut, T, Nayak, M, Nisar, NK, Nishida, S, Ogawa, S, Pakhlova, G, Pal, B, Park, CW, Park, H, Pedlar, TK, Pesantez, L, Pestotnik, R, Petric, M, Piilonen, LE, Pulvermacher, C, Ribezl, E, Ritter, M, Rostomyan, A, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Schneider, O, Schnell, G, Schwanda, C, Senyo, K, Seon, O, Sevior, ME, Shapkin, M, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Shwartz, B, Sibidanov, A, Simon, F, Sohn, Y-S, Sokolov, A, Staric, M, Steder, M, Sumihama, M, Sumisawa, K, Tamponi, U, Tanida, K, Teramoto, Y, Uchida, M, Uehara, S, Unno, Y, Uno, S, Urquijo, P, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Vorobyev, V, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Watanabe, Y, Williams, KM, Won, E, Yamamoto, H, Yashchenko, S, Yook, Y, Zhang, ZP, Zhilich, V, Zhulanov, V, and Zupanc, A
Published: 2015

48. Measurement of the (B)over-bar -> X-s gamma branching fraction with a sum of exclusive decays

Author: Saito, T, Ishikawa, A, Yamamoto, H, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Aushev, T, Ayad, R, Bakich, AM, Bansal, V, Bhuyan, B, Bobrov, A, Bondar, A, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chen, A, Cheon, BG, Chilikin, K, Cho, K, Chobanova, V, Choi, S-K, Choi, Y, Cinabro, D, Dalseno, J, Danilov, M, Dingfelder, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Gaur, V, Gabyshev, N, Ganguly, S, Garmash, A, Getzkow, D, Gillard, R, Goh, YM, Golob, B, Haba, J, Hara, T, Hasenbusch, J, Hayasaka, K, Hayashii, H, He, XH, Higuchi, T, Horiguchi, T, Hou, W-S, Hyun, HJ, Iijima, T, Inami, K, Itoh, R, Iwasaki, Y, Jaegle, I, Joffe, D, Julius, T, Kang, KH, Kato, E, Kawasaki, T, Kichimi, H, Kiesling, C, Kim, DY, Kim, HJ, Kim, JB, Kim, JH, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kronenbitter, B, Kuhr, T, Kwon, Y-J, Lange, JS, Lee, IS, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyabayashi, K, Miyata, H, Mizuk, R, Mohanty, GB, Moll, A, Mori, T, Mussa, R, Nakano, E, Nakao, M, Nakazawa, H, Nanut, T, Natkaniec, Z, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Olsen, SL, Oswald, C, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Pestotnik, R, Petric, M, Piilonen, LE, Ribezl, E, Ritter, M, Rostomyan, A, Ryu, S, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Sato, Y, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Schwartz, AJ, Senyo, K, Seon, O, Sevior, ME, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Shwartz, B, Sibidanov, A, Simon, F, Sohn, Y-S, Solovieva, E, Staric, M, Steder, M, Sumiyoshi, T, Tamponi, U, Tatishvili, G, Teramoto, Y, Trabelsi, K, Uchida, M, Uglov, T, Unno, Y, Uno, S, Urquijo, P, Ushiroda, Y, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Vorobyev, V, Vossen, A, Wagner, MN, Wang, CH, Wang, P, Wang, XL, Watanabe, M, Watanabe, Y, Williams, KM, Won, E, Yamaoka, J, Yashchenko, S, Yook, Y, Yusa, Y, Zhang, ZP, Zhilich, V, Zhulanov, V, Zupanc, A, Saito, T, Ishikawa, A, Yamamoto, H, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Aushev, T, Ayad, R, Bakich, AM, Bansal, V, Bhuyan, B, Bobrov, A, Bondar, A, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chen, A, Cheon, BG, Chilikin, K, Cho, K, Chobanova, V, Choi, S-K, Choi, Y, Cinabro, D, Dalseno, J, Danilov, M, Dingfelder, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Gaur, V, Gabyshev, N, Ganguly, S, Garmash, A, Getzkow, D, Gillard, R, Goh, YM, Golob, B, Haba, J, Hara, T, Hasenbusch, J, Hayasaka, K, Hayashii, H, He, XH, Higuchi, T, Horiguchi, T, Hou, W-S, Hyun, HJ, Iijima, T, Inami, K, Itoh, R, Iwasaki, Y, Jaegle, I, Joffe, D, Julius, T, Kang, KH, Kato, E, Kawasaki, T, Kichimi, H, Kiesling, C, Kim, DY, Kim, HJ, Kim, JB, Kim, JH, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kronenbitter, B, Kuhr, T, Kwon, Y-J, Lange, JS, Lee, IS, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyabayashi, K, Miyata, H, Mizuk, R, Mohanty, GB, Moll, A, Mori, T, Mussa, R, Nakano, E, Nakao, M, Nakazawa, H, Nanut, T, Natkaniec, Z, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Olsen, SL, Oswald, C, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Pestotnik, R, Petric, M, Piilonen, LE, Ribezl, E, Ritter, M, Rostomyan, A, Ryu, S, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Sato, Y, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Schwartz, AJ, Senyo, K, Seon, O, Sevior, ME, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Shwartz, B, Sibidanov, A, Simon, F, Sohn, Y-S, Solovieva, E, Staric, M, Steder, M, Sumiyoshi, T, Tamponi, U, Tatishvili, G, Teramoto, Y, Trabelsi, K, Uchida, M, Uglov, T, Unno, Y, Uno, S, Urquijo, P, Ushiroda, Y, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Vorobyev, V, Vossen, A, Wagner, MN, Wang, CH, Wang, P, Wang, XL, Watanabe, M, Watanabe, Y, Williams, KM, Won, E, Yamaoka, J, Yashchenko, S, Yook, Y, Yusa, Y, Zhang, ZP, Zhilich, V, Zhulanov, V, and Zupanc, A
Published: 2015

49. Measurement of e(+)e(-) -> pi(+)pi(-)psi(2S) via initial state radiation at Belle

Author: Wang, XL, Yuan, CZ, Shen, CP, Wang, P, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Ayad, R, Bakich, AM, Bansal, V, Bhuyan, B, Bobrov, A, Bonvicini, G, Bracko, M, Browder, TE, Cervenkov, D, Chang, P, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Chistov, R, Cho, K, Chobanova, V, Choi, S-K, Choi, Y, Cinabro, D, Dalseno, J, Danilov, M, Dolezal, Z, Drasal, Z, Drutskoy, A, Dutta, K, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Gaur, V, Garmash, A, Getzkow, D, Gillard, R, Goh, YM, Haba, J, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Iijima, T, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, Y, Joffe, D, Julius, T, Kang, KH, Kato, E, Kawasaki, T, Kiesling, C, Kim, DY, Kim, HJ, Kim, JB, Kim, JH, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kuzmin, A, Kwon, Y-J, Lange, JS, Lee, IS, Lewis, P, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyabayashi, K, Miyata, H, Mizuk, R, Moll, A, Mori, T, Mussa, R, Nakano, E, Nakao, M, Nanut, T, Natkaniec, Z, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Olsen, SL, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Pestotnik, R, Petric, M, Piilonen, LE, Ribezl, E, Ritter, M, Rostomyan, A, Ryu, S, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Semmler, D, Senyo, K, Shebalin, V, Shibata, T-A, Shiu, J-G, Sibidanov, A, Simon, F, Sohn, Y-S, Sokolov, A, Solovieva, E, Staric, M, Steder, M, Sumiyoshi, T, Tamponi, U, Tanida, K, Tatishvili, G, Teramoto, Y, Trabelsi, K, Uchida, M, Uglov, T, Unno, Y, Uno, S, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Wagner, MN, Watanabe, Y, Won, E, Yashchenko, S, Yusa, Y, Zhang, ZP, Zhilich, V, Zupanc, A, Wang, XL, Yuan, CZ, Shen, CP, Wang, P, Abdesselam, A, Adachi, I, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Ayad, R, Bakich, AM, Bansal, V, Bhuyan, B, Bobrov, A, Bonvicini, G, Bracko, M, Browder, TE, Cervenkov, D, Chang, P, Chekelian, V, Chen, A, Cheon, BG, Chilikin, K, Chistov, R, Cho, K, Chobanova, V, Choi, S-K, Choi, Y, Cinabro, D, Dalseno, J, Danilov, M, Dolezal, Z, Drasal, Z, Drutskoy, A, Dutta, K, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Gaur, V, Garmash, A, Getzkow, D, Gillard, R, Goh, YM, Haba, J, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Iijima, T, Inami, K, Ishikawa, A, Itoh, R, Iwasaki, Y, Joffe, D, Julius, T, Kang, KH, Kato, E, Kawasaki, T, Kiesling, C, Kim, DY, Kim, HJ, Kim, JB, Kim, JH, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kodys, P, Korpar, S, Krizan, P, Krokovny, P, Kuzmin, A, Kwon, Y-J, Lange, JS, Lee, IS, Lewis, P, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyabayashi, K, Miyata, H, Mizuk, R, Moll, A, Mori, T, Mussa, R, Nakano, E, Nakao, M, Nanut, T, Natkaniec, Z, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Olsen, SL, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Pestotnik, R, Petric, M, Piilonen, LE, Ribezl, E, Ritter, M, Rostomyan, A, Ryu, S, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Semmler, D, Senyo, K, Shebalin, V, Shibata, T-A, Shiu, J-G, Sibidanov, A, Simon, F, Sohn, Y-S, Sokolov, A, Solovieva, E, Staric, M, Steder, M, Sumiyoshi, T, Tamponi, U, Tanida, K, Tatishvili, G, Teramoto, Y, Trabelsi, K, Uchida, M, Uglov, T, Unno, Y, Uno, S, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Wagner, MN, Watanabe, Y, Won, E, Yashchenko, S, Yusa, Y, Zhang, ZP, Zhilich, V, and Zupanc, A
Published: 2015

50. Measurement of B-0 -> (Ds-KS0)pi(+) and B+ -> Ds-K+K+ branching fractions

Author: Wiechczynski, J, Stypula, J, Abdesselam, A, Adachi, I, Adamczyk, K, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Aulchenko, V, Aushev, T, Ayad, R, Bakich, AM, Bansal, V, Bhardwaj, V, Bhuyan, B, Bobrov, A, Bondar, A, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chekelian, V, Cheon, BG, Cho, K, Chobanova, V, Choi, S-K, Choi, Y, Cinabro, D, Dalseno, J, Danilov, M, Dingfelder, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Frost, O, Gaur, V, Gabyshev, N, Ganguly, S, Garmash, A, Getzkow, D, Gillard, R, Goh, YM, Grzymkowska, O, Haba, J, Hara, T, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Huschle, M, Hyun, HJ, Iijima, T, Ishikawa, A, Itoh, R, Iwasaki, Y, Jaegle, I, Joffe, D, Joo, KK, Julius, T, Kang, KH, Kato, E, Kawasaki, T, Kichimi, H, Kim, DY, Kim, JB, Kim, JH, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kodys, P, Krizan, P, Krokovny, P, Kuhr, T, Kumita, T, Kuzmin, A, Kwon, Y-J, Lange, JS, Lee, IS, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyabayashi, K, Miyata, H, Mizuk, R, Mohanty, GB, Moll, A, Mori, T, Mussa, R, Nakao, M, Nanut, T, Natkaniec, Z, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Petric, M, Piilonen, LE, Ribezl, E, Ritter, M, Rostomyan, A, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Sato, Y, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Senyo, K, Seon, O, Sevior, ME, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Shwartz, B, Sibidanov, A, Simon, F, Sohn, Y-S, Solovieva, E, Staric, M, Steder, M, Sumihama, M, Tamponi, U, Tanida, K, Tatishvili, G, Teramoto, Y, Thorne, F, Trabelsi, K, Uchida, M, Uglov, T, Unno, Y, Uno, S, Urquijo, P, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Vorobyev, V, Vossen, A, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Watanabe, M, Watanabe, Y, Williams, KM, Won, E, Yamaoka, J, Yashchenko, S, Yook, Y, Yusa, Y, Zhang, ZP, Zhilich, V, Zhulanov, V, Zupanc, A, Wiechczynski, J, Stypula, J, Abdesselam, A, Adachi, I, Adamczyk, K, Aihara, H, Al Said, S, Arinstein, K, Asner, DM, Aulchenko, V, Aushev, T, Ayad, R, Bakich, AM, Bansal, V, Bhardwaj, V, Bhuyan, B, Bobrov, A, Bondar, A, Bonvicini, G, Bozek, A, Bracko, M, Browder, TE, Cervenkov, D, Chekelian, V, Cheon, BG, Cho, K, Chobanova, V, Choi, S-K, Choi, Y, Cinabro, D, Dalseno, J, Danilov, M, Dingfelder, J, Dolezal, Z, Drasal, Z, Drutskoy, A, Eidelman, S, Farhat, H, Fast, JE, Ferber, T, Frost, O, Gaur, V, Gabyshev, N, Ganguly, S, Garmash, A, Getzkow, D, Gillard, R, Goh, YM, Grzymkowska, O, Haba, J, Hara, T, Hayasaka, K, Hayashii, H, He, XH, Hou, W-S, Huschle, M, Hyun, HJ, Iijima, T, Ishikawa, A, Itoh, R, Iwasaki, Y, Jaegle, I, Joffe, D, Joo, KK, Julius, T, Kang, KH, Kato, E, Kawasaki, T, Kichimi, H, Kim, DY, Kim, JB, Kim, JH, Kim, MJ, Kim, SH, Kim, YJ, Kinoshita, K, Ko, BR, Kodys, P, Krizan, P, Krokovny, P, Kuhr, T, Kumita, T, Kuzmin, A, Kwon, Y-J, Lange, JS, Lee, IS, Li, Y, Gioi, LL, Libby, J, Liventsev, D, Lukin, P, Matvienko, D, Miyabayashi, K, Miyata, H, Mizuk, R, Mohanty, GB, Moll, A, Mori, T, Mussa, R, Nakao, M, Nanut, T, Natkaniec, Z, Nisar, NK, Nishida, S, Ogawa, S, Okuno, S, Pakhlov, P, Pakhlova, G, Park, CW, Park, H, Pedlar, TK, Petric, M, Piilonen, LE, Ribezl, E, Ritter, M, Rostomyan, A, Sakai, Y, Sandilya, S, Santelj, L, Sanuki, T, Sato, Y, Savinov, V, Schneider, O, Schnell, G, Schwanda, C, Senyo, K, Seon, O, Sevior, ME, Shebalin, V, Shen, CP, Shibata, T-A, Shiu, J-G, Shwartz, B, Sibidanov, A, Simon, F, Sohn, Y-S, Solovieva, E, Staric, M, Steder, M, Sumihama, M, Tamponi, U, Tanida, K, Tatishvili, G, Teramoto, Y, Thorne, F, Trabelsi, K, Uchida, M, Uglov, T, Unno, Y, Uno, S, Urquijo, P, Usov, Y, Van Hulse, C, Vanhoefer, P, Varner, G, Vinokurova, A, Vorobyev, V, Vossen, A, Wagner, MN, Wang, CH, Wang, M-Z, Wang, P, Watanabe, M, Watanabe, Y, Williams, KM, Won, E, Yamaoka, J, Yashchenko, S, Yook, Y, Yusa, Y, Zhang, ZP, Zhilich, V, Zhulanov, V, and Zupanc, A
Published: 2015

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Region

Database

Publisher

1,654 results on '"Park CW"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources